Theodoros N - Ohio State University · Web viewColumbus, OH Education and Training LEAN...

CURRICULUM VITAETheodoros N. Teknos, M.D.

The Ohio State UniversityDepartment of Otolaryngology – Head & Neck Surgery

Starling-Loving Hall | 320 West Tenth Avenue Room B222 | Columbus, OH 43210

[email protected] | (614) 293-8073

Current Roles:ProfessorThe David E. Schuller, MD and Carole Schuller Chair in OtolaryngologyDivision Director, Head & Neck OncologyInterim Chair, Department of Otolaryngology

The Ohio State UniversityColumbus, OH

Education and TrainingLEAN Healthcare Institute Certification, Department of Engineering,

University of Michigan, Ann Arbor, MI May 2007Global Institute for Leadership Development, Palm Desert, CA Oct. 2006Healthcare Leadership Institute,

University of Michigan Business School, Ann Arbor, MI Sept. 2004-May 2005Fellowship, Head & Neck Oncology, Skull Base,

& Microvascular Reconstruction, Vanderbilt University Medical Center, Nashville, TN July 1996-June 1997

Residency, Otolaryngology, Massachusetts Eye & Ear Infirmary/Harvard Combined Program, Boston, MA July 1992-June 1996

Internship, General Surgery, Henry Ford Hospital, Detroit, MI July 1991-June 1992MD, Harvard Medical School, Boston, MA July 1987-June 1991BA, Chemistry, Wayne State University, Detroit, MI Sept. 1983-Apr. 1987BS, Biology, Wayne State University, Detroit, MI Sept. 1983-Apr. 1987

Certification and LicensureState of Ohio Controlled Substance License 2008-present State of Ohio Medical License #35092300 2008-presentThe American Board of Otolaryngology, Certificate # 15368 1997-presentState of Michigan Controlled Substance License 1997-2010State of Michigan Medical License # 4301057824 1997-2010State of Tennessee Medical License # 28278 1996National Board of Medical Examiners 1992

Professional AppointmentsChair, Department of Otolaryngology,

The Ohio State University, Columbus, OH Apr. 2014-presentInterim Chair, Department of Otolaryngology,

The Ohio State University, Columbus, OH Jan. 2014-Mar. 2014Vice-Chair, Department of Otolaryngology,

The Ohio State University, Columbus, OH 2011-2014

5/6/2023 Theodoros N. Teknos, MD 1

CURRICULUM VITAEDivision Director, Head & Neck Surgery, Department of

Otolaryngology-Head & Neck Surgery, The Ohio State University, Columbus, OH 2008-present

David E. & Carole Schuller Chair of Head & Neck Oncologic Surgery,Department of Otolaryngology-Head & Neck Surgery, The Ohio State University, Columbus, OH 2008-present

Professor, Department of Otolaryngology-Head & Neck Surgery, The Ohio State University, Columbus, OH 2008-present

Co-Chair of Task Force on Recurrent & Metastatic Disease, National Cancer Institute (NCI) - Head & Neck Cancer Steering Committee, Bethesda, MD 2007-present

Division Chief, Head & Neck Oncology Division, Department of Otolaryngology, University of Michigan Health System, Ann Arbor, MI 2003-2008

Associate Professor, Department of Otolaryngology, University of Michigan Medical Center, Ann Arbor, MI 2003- 2008

Professor, Department of Otolaryngology, University of Michigan Health System, Ann Arbor, MI Sept. 2008

Co-Residency Director, Department of Otolaryngology, University of Michigan Health System, Ann Arbor, MI 2006-2008

Director, Medical Student Education, Department of Otolaryngology,University of Michigan Health System, Ann Arbor, MI 2003-2006

Associate Director, Microvascular Reconstructive Surgery Program, University of Michigan Health System, Ann Arbor, MI 2000-2008

Assistant Professor, Department of Otolaryngology, University of Michigan Medical Center, Ann Arbor, MI 1997-2003

Section Head, Otolaryngology-Head & Neck Surgery, Ann Arbor Veterans' Administration Medical Center, University of Michigan, Ann Arbor, MI 1997-2001

Instructor, Head & Neck Oncology, Skull Base Surgery, & Microvascular Reconstruction, Vanderbilt University Medical Center, Nashville, TN 1996-1997

GrantsCurrent:

National Comprehensive Cancer Network, Phase I Clinical Trial to Determine the Efficacy of Vorinostat in Oropharyngeal Cancer, Principal Investigator, $300,000; 10% Salary Support 2010-2014

T-32 NCI Oncology Training Grant (PI-Caligiuri),Mentor to Luis Santaliz, $475,896; 0% Salary Support 2009-2014

National Cancer Institute RO1 (PI-Pan) Role of PKC in Oral Cancer, Co-Principal Investigator, $1,700,117; 5% Salary Support 2008-2013

SPORE in Head & Neck Cancer, Project 1 (PI-Nor): Metronomic Small Molecular Inhibitor of Bcl-2 in Head & Neck Cancer Therapy,


CURRICULUM VITAEConsultant, $1,087,363; 0% Salary Support 2008-2013

NO1 Early Therapeutics Development with Phase II Emphasis (PI-Villalona)Collaborator, $1,461,028; 0% Salary Support 2011-2013

Completed:American Cancer Society, Mechanism of PKCepsilon-Induced Tumorigenesis in Head & Neck Cancer (PI-Pan), Co- Investigator, $750,493; 10% Salary Support 2008-2012

K12 Oncology Training Grant (PI-Byrd), Mentor to Pawan Kumar, PhD, $10,000; 0% Salary Support 2010-2011

SPORE in Head & Neck Cancer - NIH/NCI, The Molecular Basis of Head & Neck Cancer Therapy – Project 5: The Use of Tetrathiomolybdate as an Anti-angiogenic Therapeutic Agent Against Human Squamous Cell Carcinoma, Principal Investigator, $1,756,908; 20% Salary Support 2002-2007

Synthes Research Award, Reconstruction of Complex Composite Oromandibular Defects Using Distraction Osteogenesis & Soft Tissue Revascularized Free Tissue Transfer,Principal Investigator, $179,671; 5% Salary Support 2002-2006

NIH T-32 Advanced Research Training Grant in Otolaryngology-Head & Neck Surgery (PI-Lesperance), Co-Principal Investigator, $148,792; 0% Salary Support 1997-2006

NIH R13 Conference Grant, The Search for an Interdisciplinary Understanding of Online Cancer Services, Co-Principal Investigator, $20,000; 0% Salary Support 2003

Pending:NCI U10, OSU as a Network Lead Academic Participating Site for the NCI NCTN (PI-Goldberg),Collaborator, $1,522,437; 5% Salary Support 2014-2019

NCI R01 (PI-Pan), Role of p300 in HPV 16 Induced Tumorigenesis, Co- Investigator, $1,923,750; 5% Salary Support 2013-2018

NCI RO1 (PI-Pan), p53 Reactivation Therapeutics for HPV Positive Head & Neck Cancer, Co- Principal Investigator, $2,489,470; 5% Salary Support 2013-2018

NCI R21 (PI-Chalmers), Quantitative Multiparameter Analysis of Rare Cells, Co-Principal Investigator, $1,256,055; 5% Salary Support 2013-2016


CURRICULUM VITAE

NCI R21 (PI-Kumar), Role of Tumor Associated Endothelial Cells in Chaperoning Tumor Cells to Distal Sites, Co-Principal Investigator, $422,875; 5% Salary Support 2013-2018

NCI RO1, (PI-Kumar), Role of IL-6 in Head & Neck Cancer Metastases, Co- Principal Investigator, $1,906,250; 5% Salary Support 2013-2018

NCI R01, (PI-Pan), Role & Regulation of Nanog in Head & Neck Cancer, Co- Principal Investigator, $1,906,250; 5% Salary Support 2013-2018

NCI, RO1 (PI-Pan), HPV Modulation of Cancer Initiating Cells in HNSCC, Co-Principal Investigator, $1,906,250; 5% Salary Support 2013-2018

NCI R01 (PI-Kumar), Development of a Novel Subcutaneous Lung Model to Study Tumor Metastasis, Co-Principal Investigator, $1,525,000; 5% Salary Support 2013-2018

Honors and AwardsAwardee, Sommer Memorial Lecture Series, Portland, OR 2013Excellence in Teaching Award, Department of Otolaryngology,

The Ohio State University College of Medicine, Columbus, OH 2013Inclusion in Best Doctors in America 2013 2012“Courage to Teach” Award for Excellence in Teaching,

The Ohio State University College of Medicine, Columbus, OH 2012Token of Appreciation from Medical Students Award (TAMS),

The University of Michigan Medical School, Ann Arbor, MI 2009Excellence in Teaching Award, Department of Otolaryngology,

The Ohio State University College of Medicine, Columbus, OH 2009Inclusion in the Global Directory of Who’s Who 2007Inclusion in Hour Magazine “Detroit’s Top Doctors” 2007Inclusion in the “Leading Health Professionals of the World”,

International Biographical Centre, Cambridge, England 2006Honor Award, American Academy of Otolaryngology-Head & Neck Surgery, Alexandria, VA 2006Leonard Tow Humanism in Medicine Award,

University of Michigan Medical School, Ann Arbor, MI 2006Founding Fellow, International Academy of Oral Oncology, London UK 2006TAMS Award, University of Michigan Medical School, Ann Arbor, MI 2006Token of Appreciation by Medical Students “TAMS” Award,

University of Michigan Medical School, Ann Arbor, MI 2005Inclusion in the “Madison Who’s Who of Executive Professionals”, Madison Who’s Who 2005Inclusion in the “Who’s Who in America”, 60th Diamond Edition, Marquis Who’s Who LLC 2005Inclusion in the Academic Keys “Who's Who in Medical Sciences Education (WWMSE)” 2005Inclusion in the “America’s Top Doctors for Cancer”, Castle Connolly Medical Ltd. 2004Inclusion in the “Best Doctors in America” Database 2003Consumer’s Research Council of America’s “Guide to America’s Top Physicians” 2003Inclusion in the “Who’s Who in Medicine and Healthcare” 2003


CURRICULUM VITAEInclusion in the “Best Doctors” Database 2003Recipient, “America’s Top Physicians” Award 2003Recipient, Frank N. Ritter Teaching Award, Department of Otolaryngology-

Head & Neck Surgery, University of Michigan, Ann Arbor, MI 2002Fellow, American Head & Neck Society 2001Fellow, American College of Surgeons (FACS) 2001Dean Lierle Resident Research Award (mentored the recipient, Dr. Claudell Cox) 2001Greek Orthodox Archdiocese Scholarship for Academic Excellence,

Harvard Medical School, Boston, MA 1991Valedictorian for Wayne State University, Detroit, MI 1987Outstanding Achievement in the Classics, Wayne State University, Detroit, MI 1987American Heart Association Competitive Research Fellowship,

Wayne State University, Detroit, MI 1986Phi Lambda Upsilon Honorary Chemical Society,

Wayne State University, Detroit, MI 1986Mortar Board Honor Society, Wayne State University, Detroit, MI 1986Phi Beta Kappa, Wayne State University, Detroit, MI 1986Outstanding Organic Chemist, Wayne State University, Detroit, MI 1985American Heart Association Competitive Research Fellowship,

Wayne State University, Detroit, MI 1985Outstanding Freshman Chemist, Wayne State University, Detroit, MI 1984

Professional Society MembershipsColumbus Ophthalmological & Otolaryngological Society (EENT Society) 2011-presentAmerican Society of Clinical Oncology 2010-presentInternational Academy of Oral Oncology 2006-presentSociety of University Otolaryngologists 2004-presentAmerican Head & Neck Society 2001-presentAmerican College of Surgeons 2001-presentAmerican Association for Cancer Research 2000-presentAmerican Board of Otolaryngology 1997-presentAmerican Academy of Otolaryngology - Head & Neck Surgery 1991-presentHead & Neck Oncology Program,

University of Michigan Cancer Center, Ann Arbor, MI 2000-2008

Peer-Review Service JAMA Otolaryngology—Head & Neck Surgery 2013-presentCancer Chemotherapy & Pharmacology 2008-presentClinical Cancer Research 2008-presentCancer Gene Therapy 2007-presentCancer Letters 2007-presentThe Journal of Pathology 2006-presentThe Lancet Oncology 2006-presentActa Oto Laryngologica 2005-presentJournal of Surgical Oncology 2005-presentBiomedical Central Cancer Reviewer 2005-presentLaryngoscope 2004-presentOral Oncology 2004-presentNeoplasia 2003-present5/6/2023 Theodoros N. Teknos, MD 5

CURRICULUM VITAEOtolaryngology-Head & Neck Surgery 2003-presentCancer 2002-presentHead and Neck Journal 2001-presentJournal of Clinical Oncology 2001-presentArchives of Otolaryngology-Head & Neck Surgery 2001-presentDepartment of Otolaryngology – Head & Neck Surgery Research Committee 1998-presentOhio Cancer Research Associates Grant Reviewer 2005

Editorial Board Oral Oncology 2006-presentORL Journal 2002-present

Teaching & MentorshipUndergraduate Students:

Thesis Committee Advisor, Jason Pradarelli Undergraduate Honors ThesisThe Ohio State University College of Literature, Arts & SciencesColumbus, OH 2011

Mentor, Multiple Students per Semester through the Alpha Epsilon Delta Shadowing ProgramUniversity of Michigan, Ann Arbor, MI 2001-2008

Faculty Advisor, BIO 300 (Independent Study/Research) for three studentsUniversity of Michigan, Ann Arbor, MI 2001

Medical Students :T-32 Oncology Training Grant Mentor to Luis Santaliz, M.D., Investigating

Cancer Initiating Cells in Head & Neck Squamous Cell Cancer,The Ohio State University Medical Center, Columbus, OH 2012-present

Faculty, Head & Neck Cancer Comprehensive Lecture Series, Department of Otolaryngology/Head & Neck Surgery, The Ohio State University, Columbus, OH 2009-present

Faculty, M1 Head & Neck Anatomy CourseThe Ohio State University, Columbus, OH 2008-present

Predoctoral Research Mentor to Amy Manning, Jessica Burgers, & Tim Shen,The Ohio State University, Columbus, OH 2012

Predoctoral Research Mentor to Azeem Kaka,The Ohio State University Medical Center, Columbus OH 2011

Predoctoral Research Mentor to Aaron Thatcher, The Ohio State University, Columbus, OH 2010

Predoctoral Research Mentor to Scott Smith,The Ohio State University, Columbus, OH 2010

Roessler Scholarship Research Mentor for Azeem Kaka & Gautam Mankaney, The Ohio State University Medical Center, Columbus, OH 2010

Predoctoral Research Mentor to Raj Mandel,The Ohio State University, Columbus, OH 2009

Predoctoral Mentor to Valerie Wood,The Ohio State University, Columbus, OH 2008Lecturer/Coordinator, “Career Seminar Series for Otolaryngology”, University of Michigan Medical School, Ann Arbor, MI 2002-2008

Co-Residency Director, Department of Otolaryngology-Head & Neck Surgery, 5/6/2023 Theodoros N. Teknos, MD 6

CURRICULUM VITAEUniversity of Michigan Health System, Ann Arbor, MI 2007-2008

Faculty, "Head & Neck Neoplastic Diseases MPC”, M2 Neurosciences Block, University of Michigan Medical School, Ann Arbor, MI 2001-2008

Faculty, "M1 Patient-Doctor Course", University of Michigan Medical School, Ann Arbor, MI 2000-2008

Faculty, Head & Neck Anatomy Component, M1 Gross Anatomy Course,University of Michigan Medical School, Ann Arbor, MI 1997-2008

T32 Research Training Grant Mentor to Dr. Samip Patel,University of Michigan Medical School, Ann Arbor, MI 2006-2007

Faculty, “Review of Head & Neck Cancer Course”, Presented by the American Head & Neck Society to Residents & Fellows Nationwide at the Annual Meeting of the American Academy of Otolaryngology-Head & Neck Surgery, Alexandria, VA 2006-2007

Director, Medical Student Education, Department of Otolaryngology-Head & Neck Surgery, University of Michigan Medical School, Ann Arbor, MI 1999-2007

Predoctoral Research Mentor to Basil Hassouneh,University of Michigan Medical School, Ann Arbor, MI 2005-2006

Course Director, “M4 Head & Neck Surgical Anatomy Course (#38927)”, University of Michigan Medical School, Ann Arbor, MI 2001-2006

T32 Research Training Grant Mentor to Manikandan Sugumaran,University of Michigan Medical School, Ann Arbor, MI 2004-2005

T32 Research Training Grant Mentor to Dr. Supriti Paul,University of Michigan Medical School, Ann Arbor, MI 2003-2004

Residents:Instructor, Daily Teaching of Resident Surgeons in Clinic & Operating Rooms 1997-presentResearch Mentor to Anna Marcinow, M.D., David Melon, M.D., &

Mike Cipolla, M.D.,The Ohio State University, Columbus, OH 2010-present

Research Mentor to Agnes Oplatek, M.D.,The Ohio State University, Columbus, OH 2009

Resident Research Committee Member, Department of Otolaryngology-Head & Neck Surgery, University of Michigan Health System, Ann Arbor, MI 2001-2008

Faculty, “Blue Team Teaching”, Weekly 3 Hour Teaching Sessions for Residents, Fellow & Students Serving on Clinical Head & Neck Oncologic Surgery Service 1997-2008

Resident Education Advisory Committee, Department of Otolaryngology-Head & Neck Surgery, University of Michigan Health System, Ann Arbor, MI 2001-2006

Research Mentor to Dr. Garfield Johnson,University of Michigan Health System, Ann Arbor, MI 2003-2004

Faculty, “Vasculogenesis, Angiogenesis & Lymphangiogenesis”, Organogenesis Graduate Student Course,

University of Michigan, Ann Arbor, MI 2004Research Mentor to Dr. Benjamin Marcus,

University of Michigan Health System, Ann Arbor, MI 2002-2003T32 Research Training Grant Co-Mentor, Dr. Matthew Rontal,


CURRICULUM VITAEUniversity of Michigan Health System, Ann Arbor, MI 2002-2003

Faculty, “Introduction to Head & Neck Cancer”, Division of Plastic Surgery, Department of General Surgery, University of Michigan Health System, Ann Arbor, MI 2001-2003

Research Mentor to Dr. Claudell Cox (Winner of Dean Lierle Resident Research Award at the Middle Section Meeting of the Triological Society, Chicago, IL 2001),University of Michigan, Ann Arbor, MI 1999-2001

Co-Editor, “Thyroid and Parathyroid Diseases & Surgery,” Monograph, Distributed by the American Academy of Otolaryngology-Head & Neck Surgery to Senior Residents at the Annual Meeting 2001 2001

Fellows:Mentor to Dr. Jon Chan,

The Ohio State University, Columbus OH 2014Mentor to Dr. Peter Dziegielewski (Appointed to Faculty,

University of Florida, Gainesville, FL),The Ohio State University, Columbus OH 2012-present

Mentor to Dr. Kiran Kakarala (Faculty, University of Kansas Medical Center, Kansas City, KS),The Ohio State University, Columbus OH 2011-2012

Mentor to Dr. Hassan Arshad (Faculty, Roswell Park Cancer InstituteBuffalo, New York),The Ohio State University, Columbus OH 2009-2010

Mentor to Dr. Bradford Bader (Faculty, Baylor Hospital, Dallas TX),The Ohio State University, Columbus OH 2008-2009

Mentor to Dr. Matthew Miller (Faculty of James Wilmot Cancer Center, University of Rochester Medical Center, Rochester, NY),The Ohio State University, Columbus OH 2007-2008

Mentor to Dr. Samir Khariwala (Faculty, University of Minnesota, Minneapolis, MN),University of Michigan Health System, Ann Arbor, MI 2006-2007

Mentor to Dr. Kelly Malloy (Faculty, University of Michigan, Ann Arbor, MI),University of Michigan Health System, Ann Arbor, MI 2006-2007

Mentor to Dr. Kevin Emerick (Faculty, Harvard/MEEI, Boston, MA),University of Michigan Health System, Ann Arbor, MI 2005-2006

Mentor to Dr. Amy Anne Lassig (Faculty, University of Minnesota, Minneapolis, MN),University of Michigan Health System, Ann Arbor, MI 2005-2006

Mentor to Dr. Christopher Lansford (Attending, Carle Clinic, Champaign, IL),University of Michigan Health System, Ann Arbor, MI 2004-

2005Mentor to Dr. Kevin Fung (Faculty, University of Western Ontario,

London, Canada),University of Michigan Health System, Ann Arbor, MI 2003-2004

Mentor to Dr. Brian Nussenbaum (Faculty, Washington University, St. Louis, MO),University of Michigan Health System, Ann Arbor, MI 2001-2002

Mentor to Dr. Larry Myers (Faculty, University of Texas-Southwestern,


CURRICULUM VITAEDallas, TX),University of Michigan Health System, Ann Arbor, MI 2000-2001

Mentor to Dr. Stephen Wang (Faculty, UCSF, San Francisco, CA),University of Michigan Health System, Ann Arbor, MI 1999-2000

Mentor to Dr. Adrienne Concus (Faculty, Kaiser Permanente, San Francisco, CA),University of Michigan Health System, Ann Arbor, MI 1998-1999

Mentor to Dr. Mark Prince (Faculty, University of Michigan, Ann Arbor, MI),University of Michigan Health System, Ann Arbor, MI 1997-1998

Conference Organization/Continuing Medical EducationMember, American Head & Neck Society Program Committee,

AHNS Annual Meeting, Chicago, IL 2006-present

Faculty, “Reconstructive Surgery After Major Ablative Head & Neck Cancer”, Practical Anatomy Workshop, St. Louis University, St. Louis, MO 2003-present

Faculty, “Sisson International Head & Neck Review Course”, Vail, CO 2002-presentMember, Scientific Program Committee for the International Head & Neck

Oncology Meetings 2009-2012Faculty, “Patient of the Month”, American Academy of Otolaryngology,

Responsible for the production of monthly interactive DVDs for CME credit 2003-2007Member, Founding Fellow and Program Committee, International Academy of Oral

Oncology, 1st World Congress, Amsterdam, Netherlands 2007Faculty, Comprehensive Course on the Multidisciplinary Management of

Head & Neck Cancer, Beth Israel Medical Center, New York, NY 2006Faculty, 4th Annual Opinion Leader Consortium on Novel & Targeted Therapeutics,

Clearwater Beach, FL 2006Tour Leader, American Head & Neck Society Annual Meeting & Research Workshop,

Chicago, IL 2006Faculty, “Laryngeal Preservation”, Henry Ford Health System

Otolaryngology Update Course, Detroit, MI 2006Faculty, Evolution of Laryngeal Cancer Treatment, Flower Hospital, Toledo, OH 2006Course Director, “The Current Usefulness of the Salivary Bypass Tube in Head &

Neck Cancer”, American Academy of Otolaryngology-Head & Neck Surgery, Los Angeles, CA 2005

Moderator, “Current Management of Head & Neck Melanoma”, Seminar at the Annual Meeting of the American Academy of Otolaryngology-Head & Neck Surgery, Los Angeles, CA 2005

Course Director, “Distraction Osteogenesis in Head & Neck Cancer”,American Academy of Otolaryngology-Head & Neck Surgery, Washington, DC 2004

Faculty, “Angiogenesis & Head & Neck Cancer”, Northeast Ohio Otolaryngology Conference, Cleveland, OH 2003

Faculty, “Current Thoughts on Laryngeal Preservation”, Northeast Ohio Otolaryngology Conference, Cleveland, OH 2003

Faculty, “Management of Parotid Malignancies”, Michigan State University School of Osteopathic Medicine, Surgery & Otolaryngology Resident Lecture Series, East Lansing, MI 2002

Faculty, “Evaluation of the Neck Mass” in “Otolaryngology for the Primary Care


CURRICULUM VITAEPhysician”, University of Michigan Medical Center, Ann Arbor, MI 1997-1999

Faculty, Phonosurgery Workshop, Vanderbilt University Medical Center, Nashville, TN 1996-1997

Committee, Organizational, & Volunteer Service International:

Founding Fellow, International Academy of Oral Oncology 2006-presentMember, Health Canada Panel for New Warning Messages on

Tobacco Products 2011Program Committee, 1st World Congress on Oral Cancer 2007

National:American Head & Neck Society (AHNS) – Education Committee 2012-presentAmerican College of Surgeons Board of Governors Advisory Council

for Otolaryngology-Head and Neck Surgery 2012-2015American Head & Neck Society (AHNS) – Publications Committee 2011-presentAmerican Head & Neck Society (AHNS) – Ad Hoc Journal Task Force 2011-present

National Cancer Institute (NCI) – Head & Neck Cancer Steering Committee, Co-Chair of Task Force on Recurrent & Metastatic Disease 2007-present

American Academy of Otolaryngology-Head & Neck Surgery Oncology Committee, Consultant 2006-present

Head & Neck Surgery & Oncology Committee, American Academy of Otolaryngology-Head & Neck Surgery 2005-present

American Head & Neck Society Annual Meeting Scientific Program Committee 2005-presentPatient of the Month Committee, American Academy of Otolaryngology-

Head & Neck Surgery 2002-presentEndocrine Surgery Committee, American Academy of Otolaryngology-

Head & Neck Surgery 2002-presentAmerican College of Surgeons Advisory Council,

American Head & Neck Society representative 2012AAO-HNS Board of Governors, 2009-2012AAO-HNS Education Committee, 2009-2012Society of University Otolaryngologists, Research Committee 2006-2008University of Michigan Tobacco Research Network 2004-2008Ohio Cancer Research Association Grant Reviewer 2006-2007Otolaryngology-Head & Neck Surgery Consulting Consortium

Clinical Advisors 2005-2007

Medical School:Learning Communities Mentor, The Ohio State University Medical Center,

Columbus, OH 2009-2012Promotion & Tenure Committee, The Ohio State University College of

Medicine, Columbus, OH 2009-2012Admissions Interview Re-design Committee, The Ohio State University

College of Medicine, Columbus, OH 2011Harvard Class 1991 20th Reunion Committee Member 2011Medical School Curriculum Re-Design Committee, The Ohio State University

College of Medicine, Columbus, OH 2008-2010


CURRICULUM VITAEMember, Fostering Innovation Grants Service (FIGS) Committee, University

of Michigan Health System 2007-2008Clinical Sciences Scholars Review Committee, University of Michigan

Health System 2005-2008Metastasis Research Interest Group, University of Michigan Cancer Center 2004-2008Bed Utilization Committee, University of Michigan Medical Center 2002-2008Institutional Review Board, University of Michigan Medical Center 2001-2004Ad Hoc Member, Graduate Medical Education Committee, Internal Review of

General Surgery, Critical Care, & Vascular Surgery Training Programs 2001University of Michigan Cancer Center Member 2000-2008Medical School Admissions Committee, University of Michigan Medical Center 2000-2008Search Committee Member for the Chief of Surgery, Ann Arbor Veterans’

Administration Medical Center, Ann Arbor, MI 2000Infection Control Committee, Ann Arbor Veterans’ Administration

Medical Center, Ann Arbor, MI 1998-2000

James Cancer Hospital & Solove Research Institute, The Ohio State University :

Service-Line Advisory Committee (S-LAC) 2014Medical Staff Officers Group 2013-presentMedical Staff Administrative Committee FY 2014 2013-2014Practitioner Evaluation Committee (PEC) 2010-presentHead and Neck Disease Committee, Co-Director 2008-presentMedical Staff Advisory Committee 2008-PresentLeadership Committee 2008-PresentQuality Committee 2008-Present

Departmental:Executive Committee, Department of Otolaryngology, The Ohio State University 2012-present

Chief of Head & Neck Division, Department of Otolaryngology, The Ohio State University 2008-present

Finance Committee, Department of Otolaryngology, The Ohio State UniversityResidency Selection Committee, Department of Otolaryngology,

The Ohio State University 2008-presentResidency Selection Committee, University of Michigan 2000-2008Research Committee, University of Michigan 1998-2000Resident Education Advisory Committee, University of Michigan 1998-2000Quality Assurance Committee, University of Michigan 1998-2000Faculty Incentive Plan Redesign Taskforce, The Ohio State University 2000Medical Student Teaching Committee, University of Michigan 1998-2008

Consulting PositionsJoan’s Foundation, Board of Directors, Columbus, OH 2008-Present Physicians Advisory Council, New York, NY 2004-presentMCare Medical Peer Consulting Panel, Ann Arbor, MI 2006-2008H3 Pharma, Montreal, CA 2005Gersham Lehman Group, New York, NY 2004-2006


CURRICULUM VITAE

Visiting Professorships, Seminars & Extramural Invited PresentationsInternational:

Moderator: “Controversial Case Studies in Oral Cancer”, 20th World Congress of the International Federation of Oto-Rhino-Laryngological Societies – IFOS Seoul 2013, Seoul, Korea, June 1-5, 2013.

Invited Speaker: “Diagnosis & Management of Parapharyngeal Space Masses” – Harvard Medical School, 20th World Congress of the International Federation of Oto-Rhino-Laryngological Societies – IFOS Seoul 2013, Seoul, Korea, June 1-5, 2013.

Invited Speaker: “Pharyngeal Reconstruction after Salvage Laryngectomy in the Era of Chemoradiation Therapy” – American Head & Neck Society, 20th World Congress of the International Federation of Oto-Rhino-Laryngological Societies – IFOS Seoul 2013, Seoul, Korea, June 1-5, 2013.

Invited Speaker: “The Use of Tetrathiomolybdate in Head & Neck Cancer”,BIT’s 3rd Annual World Cancer Congress – 2010, Singapore EXPO, Singapore, June 22-25, 2010.

Panelist: International Academy of Oral Oncology Annual Meeting, Secondary Oral Cavity Reconstruction, Toronto CA, July 7-9, 2009.

Panelist: International Academy of Oral Oncology Annual Meeting, Toronto CA, The Disappearing Jaw, July 7-9, 2009.

Moderator: International Academy of Oral Oncology Annual Meeting, State of the Art Oral Cavity Reconstruction, Toronto CA, July 7-9, 2009.

Keynote Speaker: 6th Middle Eastern Conference in Otolaryngology, Management of Recurrent Head and Neck Cancer, Abu Dhabi, UAE, April 6-8, 2009.

Keynote Speaker: 6th Middle Eastern Conference in Otolaryngology, Advanced in the Management of Laryngeal Cancer, Abu Dhabi, UAE, April 6-8, 2009.

Keynote Speaker: 6th Middle Eastern Conference in Otolaryngology, The Use of Lasers in Head & Neck Surgery, Abu Dhabi, UAE, April 6-8, 2009.

Panelist: 6th Middle Eastern Conference in Otolaryngology, Thyroid Case Conference, Abu Dhabi, UAE, April 6-8, 2009.

Moderator: Neck Masses: Benign to Malignant, Sisson Workshop, Vail, CO, Feb 9, 2009.Keynote Speaker: 3rd Macedonian Conference on Head & Neck Cancer,

Ohrid, Macedonia, State of the Art Mandible Reconstruction, Oct 19, 2008.Keynote Speaker: 3rd Macedonian Conference on Head & Neck Cancer,

Changing Treatment Paradigms in Laryngeal Cancer, Ohrid, Macedonia, October 18, 2008.

Keynote Speaker: "Advances in the Treatment of Laryngeal Cancer", 2nd Macedonia Congress on Head and Neck Cancer, Ohrid, Macedonia, October 2, 2008.

Keynote Speaker: "The Past, Present and Future of Mandibular Reconstruction", 2nd Macedonia Congress on Head and Neck Cancer, Ohrid, Macedonia, October 2,

2008. Invited Speaker: “Surgery for Advanced Laryngeal Cancer- More Than Just Salvage!!",

American Academy of Otolarygology-Head & Neck Surgery Miniseminar, Chicago, IL, September 21, 2008.

Invited Speaker: “How Can We Predict Response to Chemotherapy in Pharynx Cancer?”, 2008 Meeting of the Collegium Oto-Thino-Laryngologicum Amicitiae Sacrum,

Berlin, Germany, August 24-28, 2008.5/6/2023 Theodoros N. Teknos, MD 12

CURRICULUM VITAEVisiting Professor: “Current Treatment Paradigms in Advanced Laryngeal Cancer”,

Massachusetts Eye & Ear Infirmary, Boston, MA, May 28, 2008.Visiting Professor: “Rescue Flaps”, Maxillofacial Surgery Update,

Ann Arbor, MI, November 6, 2007.Invited Speaker: “Options for Reconstruction of Lateral Mandible Defects”, First

World Congress of the International Academy of Oral Oncology,Amsterdam, The Netherlands, May 19, 2007.

Visiting Professor: 2006 Otology/Otolaryngology Update at Virginia Mason Medical Center, Seattle, WA, November 4, 2006.

Invited Speaker: “Evolution of Treatment Paradigms in the Treatment of Laryngeal Cancer”, Virginia Mason Updates in Otolaryngology Conference, Seattle, WA, 2006.

Invited Speaker: “Contemporary Management of Head & Neck Melanoma”, Seminar, American Academy of Otolaryngology-Head & Neck Surgery Annual Meeting, Toronto, Ontario, Canada, September 18, 2006.

Invited Speaker: “Pharynx Cancer Management”, American Academy of Otolaryngology-Head & Neck Surgery Resident Education Series, Toronto, Ontario, Canada, September 16, 2006.

Invited Speaker: “Suppression of PKCε Inhibits Cell Invasion & Motility through Inactivation of Rho GTPases in HNSCC”, Annual Meeting & Research Workshop on the

Biology, Prevention & Treatment of Head & Neck Cancer, Chicago, IL, August 19, 2006.

Invited Speaker: “The Incidence of Management of Postoperative Alcohol Withdrawal Syndrome Head & Neck Cancer Patients”, American Head & Neck Society

Annual Meeting & Research Workshop on the Biology, Prevention and Treatment of Head & Neck Cancer, Chicago, IL, August 18, 2006.

Invited Speaker: “Lip Reconstruction”, American Head & Neck Society 2006 Annual Meeting & Research Workshop on the Biology, Prevention & Treatment

of Head & Neck Cancer, Chicago, IL, August 17, 2006.Invited Speaker: “Rectus Abdominus Flap”, 16th Annual Course on Multidisciplinary

Management of Head & Neck Cancer & Thyroid & Parathyroid Diseases, New York, NY, March 23, 2006.

Invited Speaker: “Superficial Inferior Epigastric Flap”, Annual Course on Multidisciplinary Management of Head & Neck Cancer & Thyroid & Parathyroid Diseases,

New York, NY, March 23, 2006.Panelist: “Panel Discussion: Salvage Surgery in the Head & Neck: Criteria For Further Surgical

Intervention & Case Presentation”, 16th Annual Course on Multidisciplinary Management of Head & Neck Cancer & Thyroid & Parathyroid Diseases, New York, NY, March 21, 2006.

Invited Speaker: “Latissimus Dorsi”, 16th Annual Course on Multidisciplinary Management of Head & Neck Cancer & Thyroid & Parathyroid Diseases, New York, NY, March 21, 2006.

Invited Speaker: “Selective Neck Dissection for the Treatment of Neck Metastases from Squamous Cell Carcinoma of the Head & Neck”, 10th International Congress on

Oral Cancer, Crete, Greece, April 23, 2005.Invited Speaker: “Leech Therapy for the Salvage of Revascularized Free Tissue Transfer with

Venous Obstruction”, 10th International Congress on Oral Cancer, Crete, Greece, April 23, 2005.

Invited Speaker: “Transport Disc Distraction Osteogenesis for the Reconstruction of Segmental Mandibular Defects”, 10th International Congress on Oral Cancer Crete, Greece,


CURRICULUM VITAEApril 22, 2005.

Invited Lecturer: “Development & Validation of the Neck Dissection Impairment Index (NDII) – A Quality of Life Measure”, 10th International Congress on Oral Cancer, Crete, Greece, April 20, 2005.

Lecturer & Panelist: “Copper & Angiogenesis Symposium,” International Society for Trace Element Research in Humans, Quebec City, Canada, September 10, 2002.

Invited Speaker: “The Need for Molecular Approaches in Head & Neck Oncology,” Fourth European Workshop on Basic Biology of Head & Neck Cancer,

Amsterdam, The Netherlands, October 4-6, 2001.

National:Keynote Speaker: “Neck dissection: operative techniques”, “Evidence-based transoral surgery

for oropharynx cancer”, Iowa Head and Neck Course, Iowa City, IA, May 19-23, 2014.Invited Speaker: University of Michigan Dissection Course, Ann Arbor, MI,

April 20, 2014.Visiting Professor: “HPV-related Head and Neck Cancer: Biology and Outcomes,” University

of North Carolina at Chapel Hill – School of Medicine, Chapel Hill, NC, March 11-12, 2014.

Visiting Professor: “Surgical Management of Oropharyngeal Cancer”, University of North Carolina at Chapel Hill – School of Medicine, Chapel Hill, NC, March 11-12, 2014.

Moderator: “Update on Rapid Changes in Treatment of Oropharyngeal Cancer”, Vanderbilt Otolaryngology Symposium, Vail, CO, February 3, 2014.

Invited Speaker: “HPV’s Link to head and Neck Cancer”, Sommer Memorial Lecture Series, Portland, OR, May 9, 2013.

Invited Speaker: “Treatment of Advanced Laryngeal Cancer”, Sommer Memorial Lecture Series, Portland, OR, May 9, 2013.

Invited Speaker: “Burnout in Medicine: Causes and Solutions”, Sommer Memorial Lecture Series, Portland, OR, May 1, 2013.

Invited Speaker: UCSF Head & Neck Cancer Update, San Francisco, CA,November 10-11, 2012.

Visiting Professor: “Clinical & Molecular Features of HPV Related Oropharyngeal Cancer, Stanford University Otolaryngology Grand Rounds, Palo Alto, CA, November 8,

2012.Invited Speaker: Protective Pharyngobasilar Fascia – A Retrospective Review Assessing the

Absence of Perineural Spread in Squamous Cell Carcinoma of the Palatine Tonsil, 2012 ASHNR, Eden Roc, Miami Beach, FL, September, 2012.

Keynote Speaker: 2nd Annual Head and Neck Cancer Management Symposia, Beaumont Health System, The Townsend, Birmingham, MI, “Prevention of Surgical Complications in Salvage Head & Neck Surgery”, July 13, 2012.

Visiting Professor: “HPV in Head & Neck Cancer, Mayo Clinic, Phoenix, AZ, July 2, 2012.

Keynote Speaker: “Head & Neck Cancer Originating from HPV”, 19th Annual Adams Lectureship, Vanderbilt University Medical Center, Nashville, TN, June 16, 2011.

Visiting Professor, Grand Rounds for Otorhinolaryngology- Head & Neck Surgery, “HPV in Head & Neck Cancers”, University of Pennsylvania, Philadelphia, PA, November 9, 2011.

Visiting Professor: HPV Related Head & Neck Cancers, St. Rita’s Hospital Cancer Symposium, Lima, OH, April 2011.


CURRICULUM VITAEVisiting Professor: Shifting Etiology & Treatment in Oropharyngeal Carcinoma,

James P. Wilmot Cancer Center, Rochester, NY, March 4, 2011. Keynote Lecturer: Head & Neck Cancer Related to HPV, Licking Memorial Hospital CME

Presentation, Newark, OH, January 31, 2011.Invited Speaker: Biology & Epidemiology of the Human Papilloma Virus, HNI Course,

The Cleveland Clinic, Cleveland, OH, August 20, 2010.Invited Speaker: “Multidisciplinary Treatment of Intermediate Stage Oral Cavity Cancer”,

2010 ASCO Annual Meeting, Chicago, IL, June 6, 2010. Invited Speaker: AAO-HNS Bridge Session for Microvascular Surgeons, Boston, MA,

September 26, 2010.Visiting Professor: University of Michigan Resident Head & Neck Dissection Course,

Parapharyngeal Space Masses, Ann Arbor, MI, March 2009.Keynote Speaker: NCCN Head & Neck Cancer Update, The Role of Surgery in Advanced

Stage Head & Neck Cancer, April 2009.Keynote Speaker: Virginia Society of Otolaryngologists, Contemporary Management of Head

& Neck Melanoma, Homestead, VA, May 5-7, 2009.Keynote Speaker: Virginia Society of Otolaryngologists, Changing Epidemiology & Treatment

of Oropharyngeal Squamous Cell Carcinoma, Homestead, VA, May 5-7, 2009.Visiting Professor: Massachusetts Eye & Ear Infirmary, Changing Treatment Patterns in

Advanced Stage Laryngeal Carcinoma, Boston, MA, July 28, 2008.Invited Speaker: “Thyroid Case Studies”, Panelist, 30th Annual Sisson Workshop, Vail, CO,

February 8, 2008.Moderator: “Treatment of Advanced Skin Malignancies”, 30th Annual Sisson Workshop,

Vail, CO, February 6, 2008.Invited Speaker: “Medical Missions: What We Can Apply Close to Home”, Vanderbilt

University School of Medicine, Annual Sisson Workshop, Vail, CO, February 7, 2007.

Invited Lecturer: “Zenker’s Diverticulum Management”, Vanderbilt University School of Medicine, Annual Sisson Workshop, Vail, CO, February 5, 2007.

Invited Lecturer: “Current Management of Advanced Laryngeal Carcinoma”, Update in Otolaryngology, Virginia Mason Hospital, Seattle, WA, September 3, 2006.

Invited Lecturer: “Bone Contouring, Plating & Soft Tissue Inset”, Practical Anatomy Workshop, Saint Louis University, St. Louis, MO, October 27, 2006.

Visiting Professor: “Current Treatment of Advanced Laryngeal Cancer”, Flower Hospital Cancer Center, Toledo, OH, October 3, 2006.

Panelist: 27th Annual Sisson Workshop, Vanderbilt School of Medicine, Vail, CO, February 5, 2006.

Invited Speaker: “Oral Cavity Lesions”, 27th Annual Sisson International Workshop, Vanderbilt School of Medicine, Vail, CO, February 11, 2005.

Invited Speaker: “Lesions of the Sinus & Skull Base”, 27th Annual Sisson International Workshop, Vanderbilt School of Medicine, Vail, CO, February 9,

2005.Keynote Speaker: “Current Thoughts on the Treatment of Laryngeal Cancer: Evolution of

Treatment Paradigms”, Northwest Ohio Otolaryngology Society, Cleveland, OH, October 13, 2004.

Keynote Speaker: “Anti-angiogenesis Therapy in Head & Neck Cancer”, Northeast Ohio Otolaryngology Society, Cleveland, OH, October 13, 2004.

Invited Speaker: “Soft Tissue Reconstruction of Defects Involving Tonsillar Fossa & Soft Palate”, Practical Anatomy Workshop, Saint Louis University, St. Louis, MO,


CURRICULUM VITAEOctober 24, 2004.

Invited Lecturer: “Anterolateral Thigh Flap Reconstruction of the Oral Tongue & Tongue Base; Harvest”, Practical Anatomy Workshop, Saint Louis University, St. Louis, MO, October 23, 2004.

Visiting Professor: "Controversies in Head & Neck Oncology", Vanderbilt University, Department of Otolaryngology – Head & Neck Surgery, Nashville, TN, June 5,

2000.Visiting Professor: "Reconstructive Surgery of the Head & Neck after Combination

Chemo/Radiotherapy", Cleveland Clinic, February 6, 2000.

Local:Invited Speaker: “Challenges and Opportunities in the Future of Otolaryngology”, Columbus

EENT Society, Columbus, OH, April 28, 2014.Keynote Lecturer: “Career in Cancer Research”, Biomedical Science-Cancer Research Course,

Columbus, OH, April 17, 2014.Keynote Speaker: “HPV in Head and Neck Cancers: Facts and Myths”, Ask the Expert,

JamesCare for Life, Columbus, OH, April 3, 2014.Invited Interview: “Toward A Cancer Free World”, Interview on Channel 10 News with Tracy

Townsend, “Latest Research in Head & Neck Cancer” during Head & Neck Cancer Awareness Month, Columbus, OH, April 18, 2013.

Keynote Speaker: “Best Practices in Oral Cancer Screening & Diagnosis”, The Joan’s Foundation Dental Community Partnership, Columbus, OH, Sept 8, 2012.

Invited Interview: “Toward A Cancer Free World” Interview on Channel 10 News with Tracy Townsend,“HPV in Head & Neck Cancer”, Columbus, OH, July 12, 1012.

Invited Interview: “Toward A Cancer Free World”, Interview on Channel 10 News with Andrea Cambern, “Oropharyngeal Cancer” during Head & Neck Cancer

Awareness Week, Columbus, OH, April 12, 2012.Keynote Speaker: Central Ohio Study Group, Ohio Dental Association “Treatment

& Reconstruction of Oral Cavity Cancer”, October 13, 2011.Keynote Speaker: 2011 Fall Cancer Symposium by ProMedica,

“HPV-Related Head & Neck Cancer”, Perrysburg, OH, October 2, 2011.Keynote Speaker: Licking Memorial Hospital Medical Staff Continuing Education Series,

“HPV-Related Head & Neck Cancer Diagnosis & Treatment”, Newark, OH, January 31, 2011.

Invited Panelist: Case-based Panel Discussion, “Controversies in Thyroid Cancer Surgery for Residual/Recurrent Differentiated & Medullary Thyroid Cancer”, Ernest L.

Mazzaferri Thyroid Cancer Conference, The Ohio State University Comprehensive Cancer Center- Arthur G. James Cancer Hospital & Richard J. Solove Research Institute, Columbus, OH,

November 19, 2010.Invited Speaker: University of Michigan, Department of Otolaryngology – H&N Surgery

Residency Training Program, H&N Dissection Course, Ann Arbor, MI, April 23-24, 2010.

Keynote Lecturer: Head & Neck Cancer Related to HPV, CME Grand Rounds, Holzer Medical Center, Gallipolis, OH, April 22, 2010.

Moderator: William B. Sauders Symposium, HPV & Head & Neck Cancer, Columbus, OH, June 18, 2009.

Speaker: William B. Saunders Symposium, Novel Antiangiogenesis Therapies for Head & Neck Cancer, Columbus OH, June 18, 2009.


CURRICULUM VITAEKeynote Speaker: NCCN Head & Neck Cancer Update, Outcomes in Head & Neck Cancer

Treatment, Columbus, OH, April 2009.Keynote Speaker: Columbus EENT Society, Recent Advances in Head & Neck Surgery,

Columbus OH, February 8, 2009.Keynote Speaker: Seminar for Veterinary Biosciences, Novel Antiangiogenesis Therapies for

Head & Neck Cancer, Columbus OH, Jan 5, 2009.Invited Speaker: Parapharyngeal Space Anatomy, Regional Flap Anatomy, University of

Michigan Otolaryngology-Head & Neck Surgery, January Dissection Course Schedule, Ann Arbor, MI, January 2009.

Keynote Speaker: The James Comprehensive Cancer Center Grand Rounds, Novel Antiangiogenesis Therapies for Head & Neck Cancer, Columbus OH, October

2008.Keynote Speaker: “Evaluation of the Thyroid Nodule”, Cancer Care Symposium,

Mercy Hospital, Port Huron, MI, November 10, 2007.

Invited Speaker: “Prognosis in Oropharyngeal Carcinoma: The Impact of Tumor Associated Macrophages”, Walter Work Society Annual Meeting, University of Michigan,

Ann Arbor, MI, October 9, 2004.Invited Speaker: “Organ Preservation Strategies in the Treatment of Head & Neck Squamous

Cell Carcinoma”, American College of Surgeons 89th Annual Clinical Congress, Chicago, IL, October 23, 2003.

Invited Speaker: “Management of Parotid Malignancies”, Michigan State University School of Osteopathic Medicine, Surgery & Otolaryngology Resident Lecture

Series, East Lansing, MI, 2002.Invited Speaker: “Evaluation of Neck Masses”, General Medical Clinical Conference,

University of Michigan Health System, Ann Arbor, MI, 2002.Invited Speaker: “Evaluation of the Neck Mass”, Instructional Course, Michigan Medical

Society Annual Meeting: 1998-2001.Invited Speaker: "Evaluation of the Neck Mass", Otolaryngology for the Primary Care

Physician course, University of Michigan Medical Center, Department of Continuing Education, Ann Arbor, MI, 1999-2000.

Invited Speaker: "Head and Neck Malignancies", Michigan Medical Society Annual Meeting, East Lansing, MI, September, 1998.

Invited Speaker: "Neck Masses: Diagnosis and Treatment", Michigan Medical Society Annual Meeting, East Lansing, MI, September, 1998.

Scientific Meeting Presentations1. Poster: "High Expression Of PRMT5 And Cyclin D1 Is Associated With Poor Outcome In

Oropharyngeal Squamous Cell Carcinoma (OPSCC) Patients And Is Inversely Associated With p16 Status", 2014 Multidisciplinary Head and Neck Cancer Symposium, Scottsdale, AZ, February 20-22, 2014.

2. Oral: “Predictors and Cost of Readmissions at an Academic Head and Neck Cancer Service”, 2013 Annual Meeting & OTO EXPO, AAO-HNSF, Vancouver, Canada, September 29, 2013.

3. Oral: “Transoral Robotic Surgery for Oropharyngeal Cancer: Long Term Quality of Life and Functional Outcomes”, Best Scientific Paper Award, American Head & Neck Society (AHNS) at Combined Otolaryngological Spring Meetings (COSM), Orlando, FL, April 10-14, 2013.

4. Poster: "Clinicopathologic Predictors of Recurrence and Overall Survival in Adenoid Cystic Carcinoma of the Head and Neck: A Single Institutional Experience at a Tertiary Care Center",


CURRICULUM VITAEAmerican Head & Neck Society (AHNS) at Combined Otolaryngological Spring Meetings (COSM), Orlando, FL, April 10-14, 2013.

5. Poster: "Highly Aggressive HPV-Related Oropharyngeal Cancer: Clinical, Radiologic, and Pathologic Characteristics”, American Head & Neck Society (AHNS) at Combined Otolaryngological Spring Meetings (COSM), Orlando, FL, April 10-14, 2013.

6. Poster: “Squamous Cell Carcinoma of the Head and Neck Unknown Primary: A Fifteen-Year Single Institution Experience”, American Head & Neck Society (AHNS) at Combined Otolaryngological Spring Meetings (COSM), Orlando, FL, April 10-14, 2013.

7. Poster: “Surgical Management of Oropharyngeal Squamous Cell Carcinoma: Survival and Functional Outcomes”, Best Poster Award, American Head & Neck Society (AHNS) at Combined Otolaryngological Spring Meetings (COSM), Orlando, FL, April 10-14, 2013.

8. Poster: “Superoylanilide Hydroxamic Acid (SAHA) – Mediated Reactivation of Tumor Suppressor microRNAs in Head & Neck Cancer”, American Head & Neck Society (AHNS) at Combined Otolaryngological Spring Meetings (COSM), Orlando, FL, April 10-14, 2013.

9. Poster: “Genetic & Chemical Targeting of Epithelial-Restricted with Serine Box Reduces Epidermal Growth Factor Receptor & Potentiates the Efficacy of Afatinib”, American Head & Neck Society (AHNS) at Combined Otolaryngological Spring Meetings (COSM), Orlando, FL, April 10-14, 2013.

10. Poster: “Polymer Encapsulation of CPT: A Promising Novel Therapeutic for Head & Neck Squamous Cell Carcinoma”, American Head & Neck Society (AHNS) at Combined Otolaryngological Spring Meetings (COSM), Orlando, FL, April 10-14, 2013.

11. Poster: “Tumor-associated Endothelial Cells Promote Tumor Metastasis by Chaperoning Circulating Tumor Cells & Protecting them from Anoikis”, American Head & Neck Society (AHNS) at Combined Otolaryngological Spring Meetings (COSM), Orlando, FL, April 10-14, 2013.

12. Poster: “Inhibition of Protein Arginine Methyltransferase-5 (PRMT-5) Decreases Cell Growth, Division, & Migration in Head & Neck Squamous Cell Carcinoma”, American Head & Neck Society (AHNS) at Combined Otolaryngological Spring Meetings (COSM), Orlando, FL, April 10-14, 2013.

13. Poster: “A Phase I trial of Vorinostat in Combination with Standard Chemoradiation Therapy in Advanced Oropharyngeal Squamous Cell Carcinoma: Preliminary Results”, 18th Annual NCCN Conference, Hollywood, FL, March 15, 2013.

14. Oral: “A Phase I trial of Vorinostat in Combination with Standard Chemoradiation Therapy in Advanced Oropharyngeal Squamous Cell Carcinoma: Preliminary Results”, NCCN Vorinostat Annual Investigator’s Meeting, 18th Annual NCCN Conference, Hollywood, FL, March 14, 2013.

15. Poster: “Anterolateral Thigh Butterfly Free Flap Reconstruction for Peristomal Recurrence Following Laryngectomy”, American College of Surgeons 98th Annual Clinical Congress, Chicago, IL, September-October, 2012.

16. Oral: “Supraclavicular Artery Island Flap for the Reconstruction of Laryngopharyngeal, Face, and Neck Defects”, American College of Surgeons 98th Annual Clinical Congress, Chicago, IL, October 2, 2012.

17. Oral: “Survival Following TORS for Oropharyneal Squamous Cell Carcinoma”, AAO-HNS Annual Meeting, Washington, D.C., September 10, 2012.


CURRICULUM VITAE18. Oral: “Cost Analysis of Robotic Surgery of the Head and Neck”, AAO-HNS Annual Meeting,

Washington, D.C., September 10, 2012.19. Oral: “Lipid-based Nanoparticle Delivery of pre-miR-107 Inhibits the Tumorigenicity of Head

& Neck Squamous Cell Carcinoma”, 8th International Head & Neck Conference, Toronto, Ontario, Canada, July 21-25, 2012.

20. Oral: “p300/CH1 Reactivates p53 to Inhibit the Tumorigenicity of HPV-Positive Head & Neck Squamous Cell Carcinoma”, 8th International Head & Neck Conference, Toronto, Ontario, Canada, July 21-25, 2012.

21. Oral: “Detection of Circulating Tumor Cells in Patients with Squamous Cell Carcinoma of the Head & Neck”, 8th International Head and Neck Conference, Toronto, Ontario, Canada, July 21-25, 2012.

22. Oral: “Micro RNA-34a Dysregulation Promotes Tumor Growth & Tumor Angiogenesis in Head & Neck Squamous Cell Carcinoma”, 8th International Head & Neck Conference, Toronto, Ontario, Canada, July 21-25, 2012.

23. Oral: “Statin (Atorvastatin) Inhibits RHoC Function in Head & Neck Squamous Cell Carcinoma”, 8th International Head and Neck Conference, Toronto, Ontario, Canada, July 21-25, 2012.

24. Oral: “ICU vs Non-ICU Postoperative Management of Head & Neck Free Flaps; Comparative Effectiveness & Cost Comparisons”, 8th International Head & Neck Conference, Toronto, Ontario, Canada, July 21-25, 2012.

25. Oral: “PRMT-5 Expression in Oropharynx Squamous Cell Carcinoma Patients May Be Predictive of Overall Survival & Inversely Related to p16 status”, 8th International Head & Neck Conference, Toronto, Ontario, Canada, July 21-25, 2012.

26. Poster: “Post Translational Phosphorylation of Nanog is Essential to Enhance Bmi-1 Levels & Promote Tumorigenesis”, 8th International Head & Neck Conference, Toronto, Ontario, Canada, July 21-25, 2012.

27. Poster: “Human Papillomavirus-16 co-opts p300 to Sensitize Cancer Initiating Cells to Cisplatin Therapy”, 8th International Head and Neck Conference, Toronto, Ontario, Canada, July 21-25, 2012.

28. Poster: “IL-6 Promotes Head & Neck Tumor Metastasis by Inducing Epithelial-Mesenchymal Transition via the JAK-STAT3-SNAIL Signaling Pathway”, 8th International Head & Neck Conference, Toronto, Ontario, Canada, July 21-25, 2012.

29. Poster: “Targeting Surviving (BIRC5) with YM155 for the Treatment of Head & Neck Squamous Cell Carcinoma”, 8th International Head and Neck Conference, Toronto, Ontario, Canada, July 21-25, 2012.

30. Poster: RhoC regulates cancer stem cells in head and neck squamous cell carcinoma by Over-expressing IL-6 and phosphorylation of STAT3, 8th International Head & Neck Conference, Toronto, Ontario, Canada, July 21-25, 2012.

31. Poster: “MicroRNA 138 Modulates Expression of RhoC in Head & Neck Squamous Cell Carcinoma”, 8th International Head & Neck Conference, Toronto, Ontario, Canada, July 21-25, 2012.

32. Poster: “Supraclavicular Artery Island Flap for the Reconstruction of Laryngopharyngeal, Face, & Neck Defects”, American College of Surgeons 98th Annual Clinical Congress in Chicago, IL, October 2, 2012.


CURRICULUM VITAE33. Poster: “NP2012-25040: Supraclavicular Artery Island Flap for the Reconstruction of

Laryngopharyngeal, Face & Neck Defects”, American College of Surgeons’ 2012 Clinical Congress, October 1, 2012.

34. Poster: “NP2012-25117: Anterolateral Thigh Butterfly Free Flap Reconstruction for Peristomal Recurrence following Laryngectomy”, American College of Surgeons’ 2012 Clinical Congress, October 1, 2012.

35. Oral: “Survival Following TORS for Oropharyneal Squamous Cell Carcinoma”, AAO-HNS Annual Meeting, Washington, D.C. September 10, 2012.

36. Oral: “Cost Analysis of Robotic Surgery of the Head and Neck”, AAO-HNS Annual Meeting, Washington, D.C., September 10, 2012.

37. Oral: “Analysis of Primary and Recurrent Adenoid Cystic Carcinoma after Radiation Therapy Using Magnetic Resonance Imaging and Diffusion Weighted Imaging”, ASNR 50th Annual Meeting, April 21-26, 2012, New York, NY.

38. Poster: “Combination of ATN224 with HSV Oncolytic Virus In Head & Neck Squamous Cell Carcinoma”, Second Place Award in the Cancer Control Category, OSUCCC-James 13th Annual Scientific Meeting, The Ohio State University, James Cancer Hospital, Columbus, OH, February 2011.

39. Oral: “Targeting Raf Kinase for the Treatment of Head & Neck Cancer”, AHNS 2010 Research Workshop, Arlington, VA, October 28-30, 2010.

40. Oral: “Biphenyl Isoxazolidine, a Novel Small MoleculeESX Mimic, Inhibits Cell Invasion, Migration, & Proliferation in Head & Neck Squamous Cell Carcinoma”, AHNS 2010 Research Workshop, Arlington, VA, October 28-30, 2010.

41. Oral: “Novel Oncolytic Virus Therapy in Squamous Cell Carcinoma”, AHNS 2010 Research Workshop, Arlington, VA, October 28-30, 2010.

42. Oral: “Human Papillomavirus Modulates Cancer Stem Cell Function in Head & Neck Squamous Cell Carcinoma”, AHNS 2010 Research Workshop, Arlington, VA, October 28-30, 2010.

43. Poster: “Dynamic Molecular Interaction Between PKCepsilon & Rhoa In Live Cells”, 2010 AHNS Research Workshop, Arlington, VA, October 28-30, 2010.

44. Poster: “MIR-107 Regulates Pkcepsilon & Inhibits the Tumorigenicity of Head & Neck Squamous Cell Carcinoma Cells”, 2010 AHNS Research Workshop, Arlington, VA,October 28-30, 2010.

45. Poster: “Dysregulation Of Microrna-34a Expression in Head & Neck Squamous Cell Carcinoma promotes Tumor Growth & Tumor angiogenesis”, 2010 AHNS Research Workshop, Arlington, VA, October 28-30, 2010.

46. Poster: “Atorvastatin Prevents Isoprenylation of RhoC in Head & Neck Squamous Cell Carcinoma”, 2010 AHNS Research Workshop, Arlington, VA, October 28-30, 2010.

47. Poster: “IL-6 predicts Recurrence Among Head & Neck Cancer Patients”, Proceedings of the 89th Annual Meeting of The American Association for Cancer Research (AACR) held at Los Angeles, CA, April 14-18, 2007.

48. Oral: “The Application of Tranport Disc Distraction Osteogenesis (TDDO) for Mandibular Reconstruction After Composite Mandibulectomy”, First World Congress of the International Academy of Oral Oncology, Amsterdam, The Netherlands, May 19, 2007.

49. Oral: “New Perspectives on Tumor Biology”, First World Congress of the International Academy of Oral Oncology, Amsterdam, The Netherlands, May 19, 2007.

50. Oral: “Multidisciplinary Treatment & the Development of Future Strategies: The Cancer Biologist as a Team Member”, First World Congress of the International Academy of Oral Oncology, Amsterdam, The Netherlands, May 19, 2007.


CURRICULUM VITAE51. Oral: “Targeting Apoptosis to Overcome Cisplatin Resistance: A Translational Study in Head &

Neck Cancer”, First World Congress of the International Academy of Oral Oncology, Amsterdam, The Netherlands, May 19, 2007.

52. Oral: “Targeting Apoptosis to Overcome Cisplatin Resistance: A Translational Study in Head & Neck Cancer”, San Diego, CA 2006.

53. Oral: “Clinical Implications of EGFR Expression and HPV Status in Advanced Stage Oropharyngeal Squamous Cell Carcinoma Patients”, EORTC 4th International Meeting on Cancer Molecular Marker, Stone Mountain, GA, September 8-10, 2006.

54. Oral: “Prevention of Wound Complications Following Salvage Laryngectomy Using Free Vascularized Tissue”, 6th International Conference on Head & Neck Cancer, Washington D.C., August 10, 2004.

55. Oral: “Prognostic Factors in Oral Cavity and Oropharyngeal Squamous Cell Carcinoma: The Impact of Tumor-Associated Macrophages”, 10th International Congress on Oral Cancer, Crete, Greece, April, 2005.

56. Oral: “The Deep Circumflex Iliac Artery Free Flap”, Mandibular Reconstruction Symposium, 10th International Congress on Oral Cancer, Crete, Greece, April, 2005.

57. Oral: “The Rectus Abdominis and Latissimus Dorsi Free Flaps”, Reconstruction of the Tongue Symposium, 10th International Congress on Oral Cancer, Crete, Greece, April, 2005.

58. Oral: “Neck Dissection Impairment Index: A Disease Specific Measure Used to Perform a Cross-Sectional Study to Evaluate Impairment & Rehabilitation after Neck Dissection”, 10th International Congress on Oral Cancer, Crete, Greece, April, 2005.

59. Oral: “Preliminary Results from a Prospective Efficacy Trial of Transport Disc Distraction Osteogenesis for the Reconstruction of Segmental Mandibular Defects”, 10th International Congress on Oral Cancer, Crete, Greece, April, 2005.

60. Oral: “p53 Expression as a Predictive Biomarker for Response to Chemo-radiation & Survival in Advanced Laryngeal Cancer”, 6th International Conference on Head & Neck Cancer, Washington D.C., August 9, 2004.

61. Oral: “Targeted Chemo-Radiation after Induction Chemotherapy Response in Advanced Oropharyngeal Cancer”, 6th International Conference on Head & Neck Cancer, Washington D.C., August 9, 2004.

62. Oral: “Predictors of Local/Regional (LR) Failure Following Parotid-Sparing Intensity Modulated Irradiation”, 6th International Conference on Head & Neck Cancer, Washington D.C., August 9, 2004.

63. Oral: “Targeted Chemo-Radiation Improves Survival Rates in Patients with Advanced Laryngeal Cancer”, 6th International Conference on Head & Neck Cancer, Washington D.C., August 9, 2004.

64. Poster: “Esophageal Dissection”, 6th International Conference on Head & Neck Cancer, Washington, D.C., August 9, 2004.

65. Poster: “Prognostic Factors in Oral Cavity and Oropharyngeal Squamous Cell Carcinoma: The Impact of Tumor-Associated Macrophages”, 6th International Conference on Head & Neck Cancer, Washington D.C., August 9, 2004.

66. Poster: “Osseocutaneous Radial Forearm Free Tissue Transfer for Repair of Complex Midfacial Defects”, 6th International Conference on Head & Neck Cancer, Washington D.C., August 9, 2004.

67. Oral: “Sentinel Node Localization for Tumors of the Head & Neck”, 6th International Conference on Head & Neck Cancer, Washington, D.C., August 9, 2004.

68. Oral: “Prospective Nested Trial of PET for Determining Tumor Response to Induction Chemoradiation Therapy”, 6th International Conference on Head & Neck Cancer, Washington, D.C., August 9, 2004.


CURRICULUM VITAE69. Oral: “Differential Expression of Angiogenesis Related Genes in the Progression of Oral Cavity

& Oropharyngeal Squamous Cell”, 6th International Conference on Head & Neck Cancer, Washington, D.C., August 9, 2004.

70. Oral: “Reconstruction of a Hemiglossectomy Defect Using a Template-Based Rectangular Free Tissue Transfer”, 6th International Conference on Head & Neck Cancer, Washington, D.C., August 8, 2004.

71. Oral: “Head & Neck Cancer Patients Have Improved Mental QOL After Surgery Despite Loss of Physical QOL”, 6th International Conference on Head & Neck Cancer, Washington, D.C., August 8, 2004.

72. Oral: “Tetrathiomolybdate (TM) Inhibits Cytokine Expression, Angiogenesis, and Tumor Growth of Squamous Cell Carcinoma”, 6th International Conference on Head & Neck Cancer, Washington, D.C., August 8, 2004.

73. Poster: “Tetrathiomolybdate (TM) Inhibits Differentiation, Migration, and Neo-Vascularization of Normal Human Endothelial Cells”, 6th International Conference on Head & Neck Cancer, Washington, D.C., August 8, 2004.

74. Poster: “The Effects of Tetrathiomolybdate on the NFκB Signaling Cascade in Human Head & Neck Squamous Cell Carcinoma”, 6th International Conference on Head & Neck Cancer, Washington, D.C., August 8, 2004.

75. Oral: Head & Neck Squamous Cell Carcinoma Induces Monocytes to Increase Expression of Angiogenic Cytokines”, 6th International Conference on Head & Neck Cancer, Washington, D.C., August 8, 2004.

76. Oral: “Predictors of Enteral Feeding Tube Placement in Head & Neck Cancer Patients”, 6th International Conference on Head & Neck Cancer, Washington D.C., August 8, 2004.

77. Oral: “The Lateral Oromandibular Defect: Is it Appropriate to Use a Bridging Reconstruction Plate Combined with a Soft Tissue Revascularized Flap?”, American Society for Reconstructive Microsurgery Annual Meeting, Palm Springs, CA, January 17-20, 2004.

78. Oral: “Head & Neck Cancer Patients Demonstrate Improved Mental Health Related QOL Following Surgery Despite Loss of Physical Health Related QOL”, ISOQOL, Prague, November, 2003.

79. Oral: “The Combination of Radiotherapy & the Angiogenesis Inhibitor Tetrathiomolybdate ™ Improves the Local Control of Squamous Cell (Head & Neck) Carcinoma Tumors in Mice”, American Society of Therapeutic Radiology and Oncology, October 19-23, 2003.

80. Oral: “Clinical Predictors of Quality of Life in Head & Neck Cancer Patients”, 11th SPORE Investigator’s Workshop, Baltimore, MD, July 8-11, 2003.

81. Oral: “Tetrathiomolybdate-Induced Copper Suppression Decreases Pro-Angiogenic Activity in Head & Neck Squamous Cell Carcinoma In Vitro & Inhibits Human Squamous Cell Carcinoma Growth In Vivo”, 11th SPORE Investigator’s Workshop, Baltimore, MD, July 8-11, 2003.

82. Oral: “Non Competing Renewal/Update on Project Number 5: The Use of Tetrathiomolybdate as an Anti-angiogenic Therapeutic Agent Against Human Squamous Cell Carcinoma Growth in Vivo”, 11th SPORE Investigator’s Workshop, Baltimore, MD, July 8-11, 2003.

83. Poster: “Improved Survival & Decreased Late Salvage Surgery with Chemo-Selection of Patients (pts) for Organ Preservation in Advanced Laryngeal Cancer”, ASCO, Chicago, IL, May 31 – June 3, 2003.

84. Oral: “Sentinel Node Localization for Tumors of the Head & Neck”, University of Michigan General Clinical Research Center (GCRC) Research Symposium, Ann Arbor, MI, April 2003.

85. Oral: “Advanced Squamous Cell Carcinoma of the Head & Neck: Efficacy of Positron Emission Tomography (PET) for Determining Tumor Regression During Concomitant Chemo-Irradiation Therapy”, University of Michigan General Clinical Research Center (GCRC) Research Symposium, Ann Arbor, MI, April 2003.


CURRICULUM VITAE86. Oral: “Molecular Profiling of Oral Cavity/Oropharynx Squamous Cell Carcinoma Demonstrates

Altered Expression of Extracellular Matrix Genes”, American Head & Neck Society Annual Meeting at COSM, Nashville, TN, May 4-6, 2003.

87. Poster: “An Approach to Restoration of the Native Orbital Aesthetic Subunit in Complex Craniofacial Defects”, Middle Section Meeting, January 17-19, 2003.

88. Oral: “Head & Neck Cancer Patients Demonstrate Improved Mental Health Related QOL Following Surgery Despite Loss of Physical Health Related QOL”, ISOQOL Meeting, November 2002.

89. Oral: “Molecular Profiling Identifies TIMP-1 Among a Set of Genes Associated with Aggressive Oral Cavity/Pharynx Tumors”, Sixth Research Workshop on the Biology, Prevention, and Treatment of Head & Neck Cancer, McLean, VA, October 9-13, 2002.

90. Oral: “Effects of Radiation on Ex Vivo Gene Therapy-Directed Osteogenesis”, American Society for Bone & Mineral Research 24th Annual Meeting, San Antonio, TX, September 2002.

91. Oral: “Reconstruction of Complex Parotidectomy Defects Using the Lateral Arm Free Tissue Transfer”, American Academy of Otolaryngology-Head & Neck Surgery Fall Meeting, September 23, 2002.

92. Oral: “Free Flaps Reduce Local Complications in Salvage Skull Base Surgery”, American Academy of Otolaryngology-Head & Neck Surgery Fall Meeting, September 23, 2002.

93. Poster: “Anti-VEGF Receptor Antibody Inhibits Squamous Cell Carcinoma Growth”, American Academy of Otolaryngology – Head & Neck Surgery Fall Meeting, Denver, CO, September 2001.

94. Oral: “Concomitant Chemoradiation for Organ Preservation in Patients with Advanced Squamous Cell Carcinoma of the Oral Cavity/Oropharynx (OC/OP)”, American Society of Clinical Oncology Annual Conference, May 2001.

95. Poster: “Mononclonal Antibody DC101 Suppresses the Growth of Squamous Cell Carcinoma in a Murine Model”, AACR Special Meeting: Angiogenesis and Cancer: From Basic Mechanisms to Therapeutic Applications, October 2000.

96. Poster: “Re-irradiation of Head and Neck Recurrent or Second Primary Cancer”, Fifth International Conference on Head & Neck Cancer, San Francisco, CA, August 2000.

97. Oral: “Prospective Swallowing Study in Patients Receiving Intensive Radiation (RT)-Chemotherapy Regimen for Head & Neck Cancer”, Fifth International Conference on Head & Neck Cancer, San Francisco, CA, August 2000.

98. Oral: “Tumor Angiogenesis as a Predictive Marker for Organ Preservation in Patients with Advanced Laryngeal Carcinoma”, Fifth International Conference on Head & Neck Cancer, San Francisco, CA, August 2000.

99. Oral: “Development & Validation of the Neck Dissection Impairment Index (NDII) – A Quality of Life Measure”, Fifth International Conference on Head & Neck Cancer, San Francisco, CA, August 2000.

100. Oral: “Sentinel Node Localization for Oral Cavity & Oropharyngeal Squamous Cell Carcinoma”, Fifth International Conference on Head & Neck Cancer, San Francisco, CA, August 2000.101. Oral: “Laryngeal Preservation: A Single Cycle of Induction Chemotherapy Followed by Chemo

radiation”, Fifth International Conference on Head & Neck Cancer, San Francisco, CA, August 2000.

102. Oral: “Positron Emission Tomography in the Evaluation of Occult Metastatic Disease in Patientswith Stage III & IV Head & Neck Cancer”, Fifth International Conference on Head & Neck Cancer, San Francisco, CA, August 2000.

103. Oral: “Phase I Study of Radiation (RT) Concurrent with Gemcitabine (GEM) for Nonresectable


CURRICULUM VITAEHead & Neck Cancer”, Fifth International Conference on Head & Neck Cancer, San Francisco, CA, August 2000.

104. Oral: “Tumor Angiogenesis as a Predictive Marker for Organ Preservation in Patients with Advanced Laryngeal Carcinoma”, American Academy of Otolaryngology – Head & Neck Surgery Annual Meeting, Washington, D.C., September 2000.

105. Oral: “The Use of Microvascular Free Tissue Transfer in the Reconstruction of Skull Base Defects”, American Academy of Otolaryngology – Head & Neck Surgery Annual Meeting, Washington, D.C., September 2000.

106. Oral: “Tissue Engineering of Injectable Cartilage”, American Academy of Otolaryngology – Head & Neck Surgery Annual Meeting, Washington, D.C., September 2000.

107. Oral: “Tumor Angiogenesis to Predict Organ Preservation in Advanced Laryngeal Cancer”,American Academy of Otolaryngology – Head & Neck Surgery Foundation Annual Meeting, Washington, D.C., September 2000.

108. Oral: “Functional Measure with Constant Shoulder Scale after Neck Dissection”, American Academy of Otolaryngology – Head & Neck Surgery Annual Meeting, Washington, D.C., September 2000.

109. Oral: “Development & Validation of the Neck Dissection Impairment Index”, American Academy of Otolaryngology – Head & Neck Surgery Annual Meeting, Washington, D.C., September 2000.

110. Poster: “Radial Forearm Free Tissue Transfers for Complex Midface Defects”, American Academy of Otolaryngology – Head & Neck Surgery Annual Meeting, Washington, D.C., September 2000.

111. Oral: “The Role of Copper Suppression as an Anti-angiogenic Strategy in Head & Neck Squamous Cell Carcinoma”, Triologic Society Middle Section Meeting, Chicago, IL,January 2000.

112. Oral: “Free Tissue Reconstruction After Organ Preservation”, Triologic Society Middle Section Meeting, Cincinnati, OH, January 1999.

113. Poster: Early Onset Radiation Induced Sarcoma", American Academy of Otolaryngology Fall Meeting, New Orleans, LA, September 1999.

114. Poster: “Radial Forearm Free Tissue Transfer in Patients with Raynaud's Phenomenon", American Association of Facial Plastic & Reconstructive Surgeons Fall Meeting, New Orleans, LA, September 1999.

115. Oral: “Head & Neck Evaluation for the Non-otolaryngologist" in the Seminar Entitled “Otolaryngology for the Non-otolaryngologist”, Ann Arbor, MI, October 26, 1999.

116. Poster: “Microvascular Free Tissue Transfer for Reconstruction of Skull Base Defects”, Combined Otolaryngological Spring Meeting (COSM), Palm Beach, FL, May 1998.

117. Poster: “New Developments in the Diagnosis of Kartagener’s Syndrome”, American Academy of Otolaryngology-Head and Neck Surgery Fall Meeting, San Francisco, CA, September 1997.

Patent Activity Quintin Pan, Longzhu Piao, & Theodoros Teknos. "Lipid-based Nanoparticle Delivery of miR-107 For Head and Neck Cancer." Filed April 2012.

Bibliography Peer-Reviewed Journals and Publications:


CURRICULUM VITAE1. Dutta S, Chatterjee M, Teknos TN, Carlson RW. “A Study of Ozone-Induced Edema in the

Isolated Rat Lung in Relation to Arachidonic Acid Metabolism, Mixed-Function Oxidases & Angiotensin Converting Enzyme Activities.” Pulmonary Pharmacology, 1990;3(2):65-72.

2. TN Teknos, MP Fried. “The Changing Etiology and Current Management of Stridor and Airway Obstruction.” Current Opinion in Otolaryngology, 1995;3:109-114.

3. Li KK, Cheney ML, Teknos TN. “The Importance of Mandibular Position in Microvascular Mandibular Reconstruction.” The Laryngoscope, 1996;106(7):903-907.

4. Teknos TN, Metson RB, Chasse T, Balercia G, Dickersin GR. “New Developments in the Diagnosis of Kartagener’s Syndrome.” Otolaryngology – Head and Neck Surgery, 1997;116(1):68-74.

5. Teknos TN, Joseph MP, Megerian CA, Friedlander RM, Weber AL. “Carotid Artery Hemorrhage from Temporal Bone Fracture.” American Journal of Otolaryngology, 1997;18(5):338-340.

6. Li KK, Teknos TN, Lauretano AM, Joseph MP. “Traumatic Optic Neuropathy Complicating Facial Fracture Repair.” Journal of Craniofacial Surgery, 1997;8(5):352-355.

7. Teknos TN, Megerian CA, Rauch SD. “Hemangioma of the Middle Ear.” Otolaryngology-Head and Neck Surgery, 1997;117(5):573-574.

8. Teknos TN. “Oropharyngeal Reconstruction.” Current Opinion in Otolaryngology, 1998;6:268-271.

9. Li KK, Teknos TN, Lai A, Lauretano AM, Joseph MP. “Traumatic Optic Neuropathy: Result in 45 Consecutive Surgically Treated Patients.” Otolaryngology – Head and Neck Surgery, 1999;120(1):5-11.

10. Eisbruch A, Dawson LA, Kim HM, Bradford CR, Terrell JE, Chepeha DB, Teknos TN, Anzar Y, Marsh LH, Martel MK, Ten Haken RK, Wolf GT, Ship JA. “Conformal and Intensity Modulated Irradiation of Head and Neck Cancer: The Potential for Improved Target Irradiation, Salivary Gland Function, and Quality of Life.” Acta Oto-Rhino-Laryngologica Belgica, 1999;53(3):271-275.

11. Li KK, Teknos TN, Lai A, Lauretano A, Terrell J, Joseph MP. “Extracranial Optic Nerve Decompression: A 10-year Review of 92 Patients.” Journal of Craniofacial Surgery, 1999;10(5):454-459.

12. Teknos TN, Myers LL. “Surgical Reconstruction after Chemotherapy or Radiation - Problems and Solutions.” Hematology - Oncology Clinics of North America, 1999;13(4):679-687.

13. Teknos TN, Poulin MD, Laruentano AM, Li KK. “Acanthamoeba Rhinosinusitis: Characterization, Diagnosis, and Treatment.” American Journal of Rhinology, 2000;14(6):387-391.

14. Eisbruch A, Shewach DS, Bradford CR, Littles JF, Teknos TN, Chepeha DB, Marentette LJ, Terrell JE, Hogikyan ND, Dawson LA, Urba S, Wolf GT, Lawrence TS. “Gemcitabine for Locally Advanced Head and Neck Cancer: A Phase I Trial and Intracellular Drug Incorporation Study.” Journal of Clinical Oncology, 2001;19(3):792-799.

15. Cox C, Teknos TN, Barrios M, Brewer GJ, Dick RD, Merajver SD. “The Role of Copper Suppression as an Anti-angiogenic Strategy in Head & Neck Squamous Cell Carcinoma.” The Laryngoscope, 2001;111:696-701.


CURRICULUM VITAE16. Teknos TN, Hogikyan ND, Wolf GT. “Conservation Laryngeal Surgery for Malignant Tumors of

the Larynx and Pyriform Sinus.” Hematology-Oncology Clinics of North America, 2001;15(2):261-276.

17. Dawson LA, Myers LL, Bradford CR, Chepeha DB, Hogikyan ND, Teknos TN, Terrell JE, Wolf GT, Eisbruch A. “Conformal Re-irradiation of Recurrent and New Primary Head and Neck Cancer.” International Journal of Radiation Oncology, Biology, Physics, 2001;50(2):377-385.

18. Teknos TN, Myers LL, Bradford CR, Chepeha DB. “Free Tissue Reconstruction of the Hypopharynx after Organ Preservation Therapy: Analysis of Wound Complications.” The Laryngoscope, 2001;111:1192-1196.

19. Teknos TN. “A Novel Anti-Angiogenesis Strategy for the Treatment of Head and Neck Cancer.” Michigan Oncology Journal, Summer 2001;3-6.

20. Taylor R, Wahl RL, Sharma PK, Bradford CR, Terrell JE, Teknos TN, Wolf GT, Chepeha DB. “Sentinel Node Localization for Oral Cavity and Oropharyngeal Squamous Cell Carcinoma.” JAMA Otolaryngology – Head and Neck Surgery, 2001; 127(8):970-974.

21. Teknos TN, Rosenthal E, Taylor R, Lee D, Marn CS. “Positron Emission Tomography in the Evaluation of Occult Metastatic Disease in Patients with Stage III and IV Head and Neck Cancer.” Head & Neck, 2001;23(12):1056-1060.

22. Taylor R, Chepeha J, Teknos TN, Bradford CR, Sharma PK, Terrell JE, Hogikyan ND, Wolf GT, Chepeha DB. ”Development and Validation of the Neck Dissection Impairment Index (NDII) – A Quality of Life Measure.” JAMA Otolaryngology – Head and Neck Surgery, 2002;128:44-49.

23. Hoff PT, Taylor RJ, Esclamado RM, Bradford CR, Teknos TN, Chepeha DB. Selective Neck “Dissection for the Treatment of Neck Metastasis from Squamous Cell Carcinoma of the Head and Neck.” The Laryngoscope, 2002;112:434-438.

24. Teknos TN, Cox C, Chepeha DB, Bradford CR, Fisher S, Wolf GT. “Tumor Angiogenesis as a Predictive Marker for Organ Preservation in Patients with Advanced Laryngeal Carcinoma.” The Laryngoscope, 2002;112(5):844-851.

25. Eisbruch A, Lyden T, Bradford CR, Haxer MJ, Miller AE, Teknos TN, Chepeha DB, Hogikyan ND, Terrell JE, Dawson LA, Wolf GT. “Objective Assessment of Swallowing Dysfunction and Aspiration following Radiation Concurrent with Chemotherapy for Head and Neck Cancer.” International Journal of Radiation Oncology, Biology, Physics, 2002;53(1):23-28.

26. Johns ME, Concus AP, Beals TF, Teknos TN. “Early-Onset Post-irradiation Sarcoma of the Head and Neck: Report of Three Cases.” ENT Journal, 2002;81(6):402-406.

27. Chepeha DB, Taylor R, Chepeha J, Teknos TN, Bradford CR, Sharma PK, Terrell JE, Wolf GT. “Functional Assessment Using Constant Shoulder Scale after Modified Radical and Selective Neck Dissection.” Head & Neck, 2002;24(5):432-436.

28. Teknos TN, Myers LM, Chepeha DB. “Raynaud’s Phenomenon in Radial Forearm Free Tissue Transfer.” ENT Journal, 2002;81(7):467-469.

29. Wolf GT, Bradford CR, Urba S, Smith A, Eisbruch A, Chepeha DB, Teknos TN, Worden F, Dawson L, Terrell JE, Hogikyan ND. “Immune Reactivity Does Not Predict Chemotherapy Response, Organ Preservation, or Survival in Advanced Laryngeal Cancer.” The Laryngoscope, 2002;112:1351-1356.


CURRICULUM VITAE30. Chepeha DB, Nussenbaum BN, Bradford CR, Teknos TN. “Leech Therapy for Patients with

Surgically Unsalvageable Venous Obstruction After Revascularized Free Tissue Transfer.” JAMA Otolaryngology – Head and Neck Surgery, 2002;128(8):960-965.

31. Teknos TN, Smith JC, Chepeha DB, Day TA, Netterville JL, Burkey BB. “The Use of Microvascular Free Tissue Transfer in Reconstructing Skull Base Defects: An Analysis of Wound Complications.” The Laryngoscope, 2002 Oct; 112 (10): 1871-1876.

32. Teknos TN, Cox C, Yoo S, Chepeha DB, Wolf GT, Bradford CR, Carey TE, Fisher SG. “Elevated Serum Vascular Endothelial Growth Factor and Decreased Survival in Advanced Laryngeal Carcinoma.” Head & Neck, 2002 Aug; 24(11):1004-1011.

33. Myers LL, Nussenbaum B, Bradford CR, Teknos TN, Esclamado RM, Wolf GT. “Paranasal Sinus Malignancies: An 18-Year Single Institution Experience.” The Laryngoscope, 2002;112(11):1964-1969.

34. Chang AE, Li Q, Jiang G, Teknos TN, Chepeha DB, Bradford CR. “Generation of Vaccine-primed Lymphocytes for the Treatment of Head and Neck Cancer.” Head & Neck, 2003;25(3):198-209.

35. Marcus B, Edwards B, Yoo S, Byrne A, Gupta A, Kandrevas J, Bradford CR, Chepeha DB, Teknos TN. “Recurrent Laryngeal Nerve Monitoring in Thyroid and Parathyroid Surgery: The University of Michigan Experience.” The Laryngoscope, 2003;113(2):356-361.

36. Nussenbaum B, Rutherford RB, Teknos TN, Dornfeld KJ, Krebsbach PH. „Ex Vivo Gene Therapy for Skeletal Regeneration in Cranial Defects Compromised by Radiotherapy.” Human Gene Therapy, 2003;14:1107-1115.

37. Cox C, Merajver SD, Yoo S, Dick RD, Brewer GJ, Lee JS, Teknos TN. “Inhibition of the Growth of Squamous Cell Carcinoma by Tetrathiomolybdate-Induced Copper Suppression in a Murine Model.” JAMA Otolaryngology – Head and Neck Surgery, 2003;129:781-785.

38. Wong AJ, Johns MM, Teknos TN. “Marjolin’s Ulcer of the Scalp.” Otolaryngology-Head and Neck Surgery, June 2003; 128 (6):915-6.

39. Eisbruch A, Ship JA, Dawson LA, Kim HM, Bradford CR, Terrell JE, Chepeha DB, Teknos TN, Hogikyan ND, Anzai Y, Marsh LH, Ten Haken RK, Wolf GT. “Salivary Gland Sparing and Improved Target Irradiation by Conformal and Intensity Modulated Irradiation of Head and Neck Cancer.” World Journal of Surgery, 2003;27(7):832-937.

40. Teknos TN, Nussenbaum B, Bradford CR, Prince ME, El-Kashlan H, Chepeha DB. “Reconstruction of Complex Parotidectomy Defects Using the Lateral Arm Free Tissue Transfer.” Otolaryngology-Head and Neck Surgery, May 2003;129(3):183-191.

41. Chepeha DB, Annich G, Pynnonen MA, Beck J, Wolf GT, Teknos TN, Bradford CR, Carroll WR, Esclamado RM. “Pectoralis Major Myocutaneous Flap vs. Revascularized Free Tissue Transfer: Complications, G-Tube Dependence, and Hospitalization.” JAMA of Otolaryngology - Head and Neck Surgery, Feb 2004;130:181-186.

42. Schmalbach CE, Chepeha DB, Giordano TJ, Rubin MA, Teknos TN, Bradford CR, Wolf GT, Kuick R, Misek DE, Trask DK, Hanash S. “Molecular Profiling Identifies Genes Associated with Metastatic Oral Cavity/Oropharynx Squamous Cell Carcinoma.” JAMA Otolaryngology-Head and Neck Surgery, 2004 Mar;130:295-302.

43. Thorne M, Harris P, Marcus K, Teknos TN. “Bilateral Vocal Fold Paresis Following Endoscopic Stapling Diverticulotomy for Zenker’s Diverticulum.” Head & Neck, 2004 Mar;26(3):294-297.


CURRICULUM VITAE44. Terrell JE, Ronis DL, Fowler KE, Bradford CR, Chepeha DB, Prince, ME, Teknos TN, Wolf GT,

Duffy SA. “Clinical Predictors of Quality of Life in Patients with Head and Neck Cancer.” JAMA Otolaryngology - Head and Neck Surgery, 2004 Apr;130:401-408.

45. Taylor JC, Terrell JE, Ronis DL, Fowler KE, Bishop C, Lamber MT, Myers LL, Duffy SA, Bradford CR, Chepeha DB, Hogikyan, Prince ME, Teknos TN, Wolf GT. “University of Michigan Head and Neck Cancer Team - Disability in Patients with Head and Neck Cancer.” JAMA Otolaryngology – Head and Neck Surgery, Jun 2004;130:764-769.

46. Eisbruch A, Marsh LH, Dawson LA, Bradford CR, Teknos TN, Chepeha DB, Worden FP, Urba S, Schipper MJ, Wolf GT. “Recurrences Near the Base-of-Skull Following IMRT of Head and Neck Cancer: Implications for Target Delineation in the High Neck, and for Parotid Sparing.” International Journal of Radiation Oncology, Biology, Physics, 2004;59:28-42.

47. Teknos TN. “Adult with Central Neck Mass.” Patient of the Month Program-American Academy of Otolaryngology-Head and Neck Surgery, 2004;33(6).

48. Moyer JE, Chepeha DB, Teknos TN. « Contemporary Skull Base Reconstruction. Current Opinion in Otolaryngology.” Current Opinion in Otolaryngology & Head and Neck Surgery, 2004;12:294-299.

49. Nussenbaum B, Teknos, TN, Chepeha DB. “Tissue engineering: The Current Status of This Futuristic Modality in Head Neck Reconstruction.” Current Opinion in Otolaryngology & Head and Neck Surgery, 2004;12:311-315.

50. Gunlauggson C, Iannetoni MA, Yu B, Teknos TN. “Thoracoscopic Management of Chyle Fistula.” ORL Journal Otorhinolaryngology and its Related Specialties, 2004;66(3):148-154 .

51. Chepeha DB, Wang SJ, Marentette LJ, Bradford CR, Boyd CM, Prince ME, Teknos TN. “Restoration of the Orbital Aesthetic Subunit in Complex Midface Defects.” The Laryngoscope, 2004;114(10):1706-1713.

52. Divi V, Fatt MA, Mukherji SK, Bradford CR, Chepeha DB, Wolf GT, Teknos TN. “Use of Cross-Sectional Imaging in Predicting Facial Nerve Sacrifice During Surgery for Parotid Neoplasms.” ORL Journal Otorhinolaryngology and its Related Specialties, 2004;66(5):262-6.

53. Perlow A, Bui C, Shreve P, Sundgren PC, Teknos TN, Mukherji SK. “High Incidence of Chest Malignancy Detected by FDG PET in Patients Suspected of Recurrent Squamous Cell Carcinoma of the Upper Aerodigestive Tract.” Journal of Computer Assisted Tomography, September/October 2004; 28(5):704-709.

54. Chepeha DB, Wang, SJ, Marentette LJ, Thompson BG, Prince ME, Teknos TN. “Radial Forearm Free Tissue Transfer Reduces Complications in Salvage Skull Base Surgery.” Otolaryngology Head and Neck Surgery, 2004;131(6):183-191.

55. Marcus B, Arenberg D, Lee J, Kleer C, Chepeha DB, Schmalbach CE, Islam M, Paul S, Pan Q, Hanash S, Kuick R, Merajver SD, Teknos TN. “Prognostic Factors in Oral Cavity and Oropharyngeal Squamous Cell Carcinoma: The Impact of Tumor-Associated Macrophages.” Cancer, 2004;101(12):2779-2787.

56. Mukherji S, Teknos TN. “The Small, Dark Tonsil in Patients Presenting with Metastatic Cervical Lymphadenopathy of Unknown Primary.” American Journal of Neuroradiology, 2005;26:206-207.

57. Teknos TN, Islam M, Arenberg DA, Pan Q, Carskadon SL, Abarbanell AM, Marcus B, Paul S, Vandenberg CD, Nor JE, Merajver SD. “Tetrathiomolybdate (TM) Modulates Cytokine


CURRICULUM VITAEExpression, Angiogenesis and Tumor Growth in Squamous Cell Carcinoma of the Head and Neck.” JAMA Otolaryngology - Head and Neck Surgery, 2005;131:204-211.

58. Divi V, Fatt MA, Teknos TN, Mukherji SK. “Use of Cross-sectional Imaging in Predicting Surgical Location of Parotid Neoplasms.” Journal of Computer Assisted Tomography, 2005;29:315-319.

59. Chepeha DB, Moyer JS, Bradford CR, Prince ME, Marentette LJ, Teknos TN. “Osseocutaneous Radial Forearm Free Tissue Transfer for Repair of Complex Midfacial Defects.” Archives of Otolaryngology-Head and Neck Surgery, Jun 2005;131:513-517.

60. Schmalbach CE, Lowe L, Teknos TN, Johnson TM, Bradford CR. “Reliability of Sentinel Lymph Node Biopsy For Regional Staging Of Head And Neck Merkel Cell Carcinoma.” Archives of Otolaryngology - Head and Neck Surgery, Jul 2005;131:610-614.

61. Pan Q, Griffith K, Kleer C, Sabel M, Teknos TN. “Protein Kinase Cepsilon Is A Predictive Biomarker Of Aggressive Breast Cancer And A Validated Target For RNA Interference Anti-Cancer Therapy.” Cancer Research, 2005;65:8366-8371.

62. Allen AM, Worden FP, Dawson LA, Bradford CR, Tsien C, Teknos TN, Chepeha DB, Hogikyan ND, Urba S, Wolf GT, Eisbruch A. “Feeding Tube Placement Facilitates Aggressive Hyperfractionated Chemoradiation (HxCRT) for Unresectable Head and Neck Cancer.” International Journal of Radiation Oncology, Biology, Physics, Sept 2005;60(1)suppl 1:S510-S511.

63. Feng M, Jabbari S, Lin A, Bradford C, Chepeha DB, Teknos TN, Worden FP, Tsien C, Schipper M, Wolf GT, Dawson LA, Eisbruch A. “Predictive Factors Of Local-Regional Recurrences Following Parotid Sparing 3D Conformal And Intensity Modulated Radiotherapy For Head and Neck Cancer.” Radiotherapy and Oncology Journal, Oct 2005;77(1):32-38.

64. Lin A, Jabbari S, Worden F, Bradford CR, Chepeha DB, Teknos TN, Liao JJ, Nyquist chipper MJ, Urba S, Wolf GT, Eisbruch A. “Metabolic Abnormalities Associated with Weight Loss During Chemo-Irradiation of Head and Neck Cancer.” International Journal of Radiation Oncology, Biology, Physics, Dec 2005;63(5):1413-1418.

65. Fung K, Lyden TH, Lee J, Urba SG, Worden F, Eisbruch A, Tsien C, Bradford CR, Chepeha DB, Hogikyan ND, Prince MEP, Teknos TN, Wolf GT. “Voice and Swallowing Outcomes of an Organ-Preservation Trial for Advanced Laryngeal Cancer.” International Journal of Radiation Oncology, Biology, Physics, Dec 2005;63(5):1395-1399.

66. Teknos TN. “Adult with a Central Neck Mass.” Patient of the Month Program, Otolaryngology, 2005; Volume 33: Number 6.

67. Teknos TN. “Adult with Muffled Voice.” Patient of the Month Program, Otolaryngology, 2005; Volume 35: Number 1.

68. Urba S, Wolf GT, Eisbruch A, Worden F, Lee JS, Bradford CR, Teknos TN, Chepeha DB, Prince ME. “Single-Cycle Induction Chemotherapy Selects Patients with Advanced Laryngeal Cancer for Combined Chemoradiation: A New Treatment Paradigm.” Journal of Clinical Oncology, Feb 2006;24(4):593-598.

69. Gandhi D, Chepeha DB, Karachumdani R, Miller T, Carlos RC, Bradford CR, Worden F, Eisbruch A, Teknos TN, Wolf GT, Mukherji SK. “Correlation Between Initial and Early Follow-up CT Perfusion Parameters with Clinical Tumor Response in Patients with Advanced Squamous


CURRICULUM VITAECell Carcinoma of Oral Cavity/Oropharynx Treated with Organ Preservation Therapy.” American Journal of Neuroradiology, 2006; 27: 101-106.

70. Pan Q, Bao LW, Teknos TN, Merajver SD. “Target Disruption of Protein Kinase Cε Inactivates and Alters the Phosphorylation Status of RhoA, Rac1, and Cdc42 GTPases in Head and Neck Squamous Cell Carcinoma.” Cancer Research, 2006; 66: 9379-9384.

71. Lansford CL, Teknos TN. “Evaluation of the Thyroid Nodule.” Cancer Control, Apr 2006;13(2):89-98.

72. Khan MK, Mamou F, Schipper MJ, May KS, Kwitny A, Warnat A, Bolton B, Nair BM, Kariapper MST, Miller M, Brewer G, Normolle D, Merajver SD, Teknos TN. “Combination of Tetrathiomolybdate and Radiation in a Mouse Model of Head and Neck Squamous Cell Carcinoma.” JAMA Otolaryngology - Head and Neck Surgery, Mar 2006;132:333-338.

73. Allen AM, Elshaikh M, Worden FP, Bradford CR, Teknos TN, Chepeha DB, Tsien C, Dawson LA, Urba S, Wolf GT, NormolleD, Eisbruch A. “Acceleration of Hyperfractionated Chemoradiation Regimen for Advanced Head and Neck Cancer.” Head & Neck, 2006; 29(2):137-142.

74. Kleer CG, Teknos TN, Islam M, Marcus B, Lee JS, Pan Q, Chepeha DB, Merajver SD. “RhoC-GTPase Expression as a Potential Marker of Lymph Node Metastasis in Squamous Cell Carcinoma of the Head and Neck.” Clinical Cancer Research, 2006;12: 4485-4490.

75. Cheng SS, Terrell JE, Bradford CR, Ronis DL, Fowler KE, Prince ME, Teknos TN, Wolf GT, Duffy SA. “Variables Associated with Feeding Tube Placement in Head and Neck Cancer.” JAMA Otolaryngology-Head and Neck Surgery, 2006;132:655-661.

76. Duffy SA, Ronis DL, Valenstein M, Fowler KE, Lambert MT, Bishop C, Terrell JE, and the University of Michigan Head and Neck Cancer Team. “Depressive Symptoms, Smoking, Drinking, and Quality of Life Among Head and Neck Cancer Patients.” Psychosomatics, 2007;48:142-148.

77. Zima A, Carlos R, Gandhi D, Case I, Teknos TN, Mukherji S. “Can Pretreatment CT Perfusion Predict Response of Advanced Squamous Cell Carcinoma of the Upper Aerodigestive Tract Treated with Induction Chemotherapy?” American Journal of Neuroradiology, Feb 2007; 28: 328 – 334.

78. Allen C, Duffy S, Teknos TN, Islam, M, Chen Z, Albert PS, Wolf GT, Van Waes C. “Nuclear Factor –κB-Related Serum Factors as Longitudinal Biomakers of Response and Survival in Advanced Oropharyngeal Carcinoma.” Clinical Cancer Research, 2007;13(11):3182-3190.

79. Fung K, Teknos TN, Vandenberg CD, Lyden TH, Hogikyan ND, Bradford CR, Prince ME, Wolf GT, Chepeha DB. “Prevention of Wound Complications Following Salvage Laryngectomy Using Free Vascularized Tissue.” Head & Neck, 2007:29(5);425-430.

80. Hassouneh B, Islam M, Nagel T, Pan Q, Merajver SD, Teknos TN. “Tetrathiomolybdate Promotes Tumor Necrosis and Prevents Distant Metastases by Suppressing Angiogenesis in Head and Neck Cancer.” Molecular Cancer and Therapeutics, 2007:6;1039-1045.

81. Bauer JA, Kumar B, Cordell K, Prince ME, Tran HH, Wolf GT, Chepeha DB, Teknos TN, Wang S, Eisbruch A, Tsien C, Urba SG, Worden FP, Lee JS, Griffith KA, Taylor JM, D’Silva NJ, Wang S, Wolter KG, Hendson B, Fisher SG, Carey TE, Bradford CR. “Targeting Apoptosis to Overcome Cisplatin Resistance: A Translational Study in Head and Neck Cancer.” International Journal of Radiation Oncology, Biology, Physics, 2007:69(2 Suppl);S106-108.


CURRICULUM VITAE82. Kumar B, Cordell KG, Lee JS, Prince ME, Tran HH, Wolf GT, Urba SG, Worden FP, Chepeha

DB, Teknos TN, Eisbruch A, Tsien CI, Taylor JM, D’Silva NJ, Yang K, Kurnit DM, Bradford CR, Carey TE. “Response to Therapy and Outcome in Oropharyngeal Cancer are Associated with Biomarkers Including HPV, EGFR, Gender and Smoking.” International Journal of Radiation Oncology, Biology, Physics, 2007:69 (2 Suppl);S109-111.

83. Emerick KS and Teknos TN. “State of the Art Mandible Reconstruction Using Revascularized Free Tissue Transfer.” Expert Review of Anti-Cancer Therapy, 2007:7; 1781-1788.

84. Emerick KS, Tomycz L, Bradford CR, Lyden TH, Chepeha DB, Wolf GT, Teknos TN. “Primary Versus Secondary Tracheoesophageal Puncture in Salvage Total Laryngectomy following Chemoradiation.” Otolaryngology - Head and Neck Surgery, 2009 Mar;140(3):386-90.

85. Worden FP, Kumar B, Lee JS, Wolf GT, Cordell KG, Taylor JMG, Urba SG, Eisbruch A, Teknos TN, Chepeha DB, Prince ME, Tsien CI, DiSilva NJ, Miller TH, Wallace NE, Bauer JA, Bradford CR, Carey TE. “Chemoselection as a Strategy for Organ Preservation in Advanced Oropharynx Cancer: Response and Survival Positively Associated with HPV16 Copy Number.” Journal of Clinical Oncology, Jul 1 2008:3128-3137.

86. Worden FP, Kumar B, Lee JS, Wolf GT, Cordell KG, Taylor JMG, Urba SG, Eisbruch A, Teknos TN, Chepeha DB, Prince ME, Tsien CI, DiSilva NJ, Miller TH, Wallace NE, Bauer JA, Bradford CR, Carey TE. “EGFR, p16, HPV Titer, BclXL and p53, Gender and Smoking as Indicators of Response to Therapy and Survival in Oropharyngeal Cancer.” Journal of Clinical Oncology, Ju1 2008: 3138 – 3146.

87. Cao Y, Popovtzer A, Li D, Chepeha DB, Moyer JS, Prince ME, Worden F, Teknos TN, Bradford C, Mukherji SK, Eisbruch A. “Early Prediction Of Outcome In Advanced Head and Neck Cancer Based On Tumor Blood Volume Alterations During Therapy: A Prospective Study.” International Journal of Radiation Oncology, Biology, Physics, Dec 2008; 72(5):1287-90.

88. Chepeha DB, Teknos TN, Shargorodsky J, SaccoAG, Lyden T, Prince ME, Bradford CR, Wolf GT. “Rectangle Tongue Template for Reconstruction of the Hemiglossectomy Defect.” JAMA Otolaryngology - Head and Neck Surgery, 2008;134(9):993-998.

89. Lansford CD, Guerriero CH, Kocan MJ, Turley R, GrovesMW, Bahl V, Abrahamse P, Bradford CR, Chepeha DB, Moyer J, Prince ME, Wolf GT, Aebersold ML, Teknos TN. “Improved Outcomes in Patients With Head and Neck Cancer Using a Standardized Care Protocol for Postoperative Alcohol Withdrawal.” JAMA Otolaryngology - Head and Neck Surgery, 2008;134(8):865-872.

90. Kumar B, Cordell KG, Lee JS, Worden FP, Prince ME, Tran HH, Wolf GT, Urba SG, Chepeha DB, Teknos TN, Eisbruch A, Tsien CI, Taylor JM, D'Silva NJ, Yang K, Kurnit DM, Bauer JA, Bradford CR, Carey TE. “EGFR, p16, HPV Titer, Bcl-xL and P53, Sex, and Smoking as Indicators of Response to Therapy and Survival in Oropharyngeal Cancer.” Journal of Clinical Oncology, Jul 2008; 26(19):3128-37.

91. Duffy SA, Taylor JM, Terrell JE, Islam M, Li Y, Fowler KE, Wolf GT, Teknos TN. “Interleukin-6 Predicts Recurrence and Survival among Head and Neck Cancer Patients.” Cancer, Aug 2008; 113(4):750-7.

92. Ashimori N, Zeitlin BD, Zhang Z, Warner K, Turkienicz IM, Spalding AC, Teknos TN, Wang S, Nor JE. “TW-37, A Small-Molecule Inhibitor of Bcl-2, Mediates S-phase Cell Cycle Arrest and Suppresses Head and Neck Tumor Angiogenesis.” Molecular Cancer Therapeutics, Apr 2009; 8(4):893-903.


http://www.ncbi.nlm.nih.gov/pubmed?term=%22Primary%20Versus%20Secondary%20Tracheoesophageal%20Puncture%20in%20Salvage%20Total%20Laryngectomy%20Following%20Chemoradiation%22

http://www.ncbi.nlm.nih.gov/pubmed?term=Teknos%20TN%5BAuthor%5D&cauthor=true&cauthor_uid=19248948

http://www.ncbi.nlm.nih.gov/pubmed?term=Wolf%20GT%5BAuthor%5D&cauthor=true&cauthor_uid=19248948

http://www.ncbi.nlm.nih.gov/pubmed?term=Chepeha%20DB%5BAuthor%5D&cauthor=true&cauthor_uid=19248948

http://www.ncbi.nlm.nih.gov/pubmed?term=Lyden%20TH%5BAuthor%5D&cauthor=true&cauthor_uid=19248948

http://www.ncbi.nlm.nih.gov/pubmed?term=Bradford%20CR%5BAuthor%5D&cauthor=true&cauthor_uid=19248948

http://www.ncbi.nlm.nih.gov/pubmed?term=Tomycz%20L%5BAuthor%5D&cauthor=true&cauthor_uid=19248948

http://www.ncbi.nlm.nih.gov/pubmed?term=Emerick%20KS%5BAuthor%5D&cauthor=true&cauthor_uid=19248948

CURRICULUM VITAE93. Popovtzer A, Gluck I, Chepeha DB, Teknos TN, Moyer JS, Prince ME,m Bradford CR, Eisbruch

A. “The Pattern of Failure After Re-irradiation of Recurrent Squamous Cell Head and Neck Cancer; Implications for Defining the Targets.” International Journal of Radiation Oncology, Biology, Physics, 2009 August 1;74(5)1342-7.

94. Chepeha DB; Sacco AG; Oxford LE; Karamchandani R; Miller TH; Teknos TN; Bradford CR; Eisbruch A; Worden FM; Urba SG; Mukherji SK; Bui C; Frey KA; Wolf GT; Lee JS. “Advanced Squamous Cell Carcinoma of the Oropharynx: Efficacy of Positron Emission Tomography and Computed Tomography for Determining Primary Tumor Response during Induction Chemotherapy.” Head & Neck, 2009; Vol. 31, no. 4 (April 1): 452.

95. Ash L, Teknos TN, Gandhi D, Patel S, Mukherji SK. Head and neck squamous cell carcinoma: CT perfusion can help noninvasively predict intratumoral microvessel density. Radiology; May 2009; 251(2):422-8.

96. Gluck I, Ibrahim M, Popovtzer A, Teknos TN, Chepeha DB, Prince ME, Moyer JS, Bradford CR, Eisbruch A. “Skin Cancer of the Head and Neck with Perineural Invasion; Defining the Clinical Target Volumes Based on the Pattern of Failure.” International Journal of Radiation Oncology Biology, Physics, 2009 May 1:74(1)38-46

97. Bao L, Gorin MA, Zhang M, Ventura AC, Pomerantz WC, Merajver SD, Teknos TN, Mapp AK, Pan Q. “Preclinical Development of a Bifunctional Cancer Cell Homing, PKCepsilon Inhibitory Peptide for the Treatment of Head and Neck Cancer.” Cancer Research, Jul 2009; 69(14):5829-34.

98. Worden FP; Moyer J; Lee JS; Taylor JM; Urba SG; Eisbruch A; Teknos TN; Chepeha DB; Prince ME; Hogikyan N; Lassig AA; Emerick K; Mukherji S; Hadjiski L; Tsien CI; Miller TH; Wallace NE; Mason HL; Bradford CR; Wolf GT. “Chemoselection as a Strategy for Organ Preservation in Patients with T4 Laryngeal Squamous Cell Carcinoma with Cartilage Invasion.” The Laryngoscope, 2009; Vol. 119, no. 8 (August 1): 1510.

99. Chepeha DB, Sacco AG, Erickson VR, Lyden T, Haxer M, Moyer J, Teknos TN, Prince ME, Eisbruch A, Bradford CR, Wolf GT. “Oropharyngoplasty with Template-based Reconstruction of Oropharynx Defects.” Archives of Otolaryngology – Head and Neck Surgery, 2009 Sep135(9)887-94.

100. Pan Q, Gorin MA, Teknos TN. “Pharmacotherapy of Head and Neck Squamous Cell Carcinoma.” Expert Opinion on Pharmacotherapy, Oct 2009; 10(14):2291-302.

101. Islam M; Lin G; Brenner JC; Pan Q; Merajver SD; Hou Y; Kumar P; Teknos TN. “RhoC Expression and Head and Neck Cancer Metastasis.” Molecular Cancer Research 2009; Vol. 7, no. 11 (November 1): 1771.

102. Kumar P; Yadav A; Patel SN; Islam M; Pan Q; Merajver SD; Teknos TN. “Tetrathiomolybdate Inhibits Head and Neck Cancer Metastasis by Decreasing Tumor Cell Motility, Invasiveness and by Promoting Tumor Cell Anoikis.” Molecular Cancer, 2010; Vol. 9 (January 1): 206.

103. Maxwell JH; Kumar B; Feng FY; Worden FP; Lee JS; Eisbruch A; Wolf GT; Prince ME; Moyer JS; Teknos TN; Chepeha DB; McHugh JB; Urba SG; Stoerker J; Walline HM; Kurnit DM; Cordell KG; Davis SJ; Ward PD; Bradford CR; Carey TE. “Tobacco Use in Human Papillomavirus-positive Advanced Oropharynx Cancer Patients Related to Increased Risk of Distant Metastases and Tumor Recurrence.” Clinical Cancer Research: An Official Journal Of The American Association For Cancer Research, 2010; Vol. 16, no. 4 (February 15): 1226.


CURRICULUM VITAE104. Maxwell JH; Kumar B; Feng FY; McHugh JB; Cordell KG; Eisbruch A; Worden FP; Wolf GT;

Prince ME; Moyer JS; Teknos TN; Chepeha DB; Stoerker J; Walline H; Carey TE; Bradford CR. “HPV-positive/p16-positive/EBV-negative Nasopharyngeal Carcinoma in White North Americans.” Head & Neck, 2010; Vol. 32, no. 5 (May 1): 562.

105. Divi V; Worden FP; Prince ME; Eisbruch A; Lee JS; Bradford CR; Chepeha DB; Teknos TN; Hogikyan ND; Moyer JS; Tsien CI; Urba SG; Wolf GT. “Chemotherapy Alone for Organ Preservation in Advanced Laryngeal Cancer.” Head & Neck, 2010; Vol. 32, no. 8 (August 1): 1040.

106. Divi, V, Worden FP, Prince ME, Eisbruch A, Lee JS, Brandford CR, Chepeha DB, Teknos TN, Hogikyan ND, Moyer JS, Tsien CI, Urba SG, Wolf GT. “Chemotherapy Alone for Organ Preservation in Advanced Laryngeal Cancer. Head & Neck, 2010 Aug 32(8)1040-7.

107. Contag, SP, Golub JS, Teknos TN, Nussenbaum B, Stack BC Jr, Arnold DJ, Johns MM 3rd. “Professional Burnout among Microvascular and Reconstructive Free Flap Head and Neck Surgeons in the United States.” Archives of Otolaryngology - Head and Neck Surgery, 2010 Oct 136(10);950-6.

108. Jatana, K, Balasubramanian P, Lang Jatana CA, White E, Agrawal A, Ozer E, Schuller DE, Teknos TN, Chalmbers J. “Significance of Circulating Tumor Cells in Patients with Squamous Cell Carcinoma of the Head and Neck; Initial Results.” Archives of Otolaryngology – Head and Neck Surgery, 2010 Dec; 136(12)1274-9.

109. Bhave SL, Teknos TN, Pan Q. “Molecular Parameters of Head and Neck Cancer Metastasis.” Critical Review of Eukaryotic Gene Expression, 2011;21(2):143-53.

110. McClurg SW, Leon M, Teknos T, Iwenofu O. “Chondromyxoid Fibroma of the Nasal Septum; Case Report and Review of Literature.” Head & Neck, 2011 May 4.

111. Lassig AA, Donatelli PE, Teknos TN. “Recalcitrant Hypocalcemia in a Lactating Woman after Total Thyroidectomy for Papillary Thyroid Carcinoma.” Head & Neck, 2011 Jun;33(6):920-2.

112. Yadav A, Kumar B, Teknos TN, Kumar P. “Sorafenib Enhances the Antitumor Effects of Chemoradiation Treatment by Downregulating ERCC-1 and XRCC-1 DNA Repair Proteins.” Molecular Cancer and Therapeutics, 2011 July 10(7)1241-561.

113. Hurtuk A, Teknos TN, Ozer E. “Robotic-Assisted Lingual Tonsillectomy.” The Laryngoscope, 2011 Jul;121(7)1480-2.

114. Hurtuk A, Agrawal A, Old M, Teknos TN, Ozer E. “Outcomes of Transoral Robotic Surgery; A Preliminary Clinical Experience.” Otolaryngology - Head and Neck Surgery, 2011 Aug;145 (2)248-53.

115. Hurtuk A, Agrawal A, Old M, Teknos TN, Ozer E. “Quality of Life Outcomes in Transoral Robotic Surgery.” Otolaryngology - Head and Neck Surgery, 2011 Aug;145 (2):248-53.

116. Yadav A, Kumar B, Datta J, Teknos TN, Kumar P. “IL-6 Promotes Head and Neck Tumor Metastasis by Inducing Epithelial-mesenchymal Transition via the JAK-STAT3-SNAIL Signaling Pathway.” Molecular Cancer Research. 2011 Dec;9(12):1658-67.

117. Balasubramanian P, Lang JC, Jatana KR, Miller B, Ozer E, Old M, Schuller DE, Agrawal A, Teknos TN, Summers TA, Lustberg MB, Zborowski M, Chalmers JJ: “Multiparameter Analysis, including EMT Markers, on Negatively Enriched Blood Samples from Patients with Squamous Cell Carcinoma of the Head and Neck”. PLoS One, July 26, 2012.


http://www.ncbi.nlm.nih.gov/pubmed/22077153

CURRICULUM VITAE118. Ozer E, Alvarez B, Kakarala K, Durmus K, Teknos TN, Carrau RL. “Clinical Outcomes of

Transoral Robotic Supraglottic Laryngectomy.” Head & Neck, 2012 Aug 21.

119. Luedke E, Jaime-Ramirez AC, Bhave N, Roda J, Choudhary MM, Kumar B, Teknos TN, Carson WE 3rd. “Cetuximab Therapy in Head and Neck Cancer: Immune Modulation with Interleukin-12 and Other Natural Killer Cell-activating Cytokines.” Surgery, 2012 Sep;152(3):431-40. Epub 2012 Jul 6.

120. Yoo JY, Pradarelli J, Haseley A, Wojton J, Kaka A, Bratasz A, Alvarez- Breckenridge CA, Yu JG, Powell K, Mazar AP, Teknos TN, Chiocca EA, Glorioso JC, Old M, Kaur B. “Copper Chelation Enhances Antitumor Efficacy and Systemic Delivery of Oncolytic HSV.” Clinical Cancer Research, 2012 Sep 15;18(18):4931-4941.

121. Kumar B, Yadav A, Lang JC, Cipolla MJ, Schmitt AC, Arradaza N, Teknos TN, Kumar P. “YM155 Reverses Cisplatin Resistance in Head and Neck Cancer by Decreasing Cytoplasmic Survivin Levels.” Molecular Cancer and Therapeutics, 2012 Sep;11(9):1988.

122. Kumar B, Yadav A, Lang J, Teknos TN, Kumar P. “Dysregulation of MicroRNA-34a Expression in Head and Neck Squamous Cell Carcinoma Promotes Tumor Growth and Tumor Angiogenesis.” PLoS One, 2012;7(5):e37601.

123. Piao L, Zhang M, Datta J, Xie X, Su T, Li H, Teknos TN, Pan Q. “Lipid-based Nanoparticle Delivery of Pre-miR-107 Inhibits the Tumorigenicity of Head and Neck Squamous Cell Carcinoma.” Molecular Cancer and Therapeutics, 2012 Jun;20(6):1261-9.

124. Datta J, Smith A, Lang JC, Islam M, Dutt D, Teknos TN, Pan Q. “MicroRNA-107 Functions as a Candidate Tumor-suppressor Gene in Head and Neck Squamous Cell Carcinoma by Downregulation of Protein Kinase Cɛ.” Oncogene, 2012 Sep 6;31(36):4045-53.

125. Smith A, Teknos TN, Pan Q. “Epithelial to Mesenchymal Transition in Head and Neck Squamous Cell Carcinoma.” Oral Oncology, October 2012.

126. Duffy SA, Teknos TN, Taylor JM, Fowler K, Islam M, Wolf GT, McLean SA, Ghanem TA, Terrell JE. “Health Behaviors Predict Higher Interleukin-6 levels Among Patients Newly Diagnosed with Head and Neck Squamous Cell Carcinoma.” Cancer Epidemiology Biomarkers

and Prevention, 2013 Jan 8.

127. Xie X, Piao L, Bullock BN, Smith A, Su TZ, Zhang M, Teknos TN, Arora PS, and Pan Q. “Targeting HPV16 E6-p300 Interaction Reactivates p53 and Inhibits the Tumorigenicity of HPV-positive Head and Neck Squamous Cell Carcinoma.” Oncogene. 2014 Feb 20; 33(8):1037-46. doi: 10.1038/onc.2013.25. Epub 2013 Mar 11.

128. Dziegielewski PT, Teknos TN, Durmus K, Old M, Agrawal A, Kakarala K, Marcinow A, Ozer E. “Transoral Robotic Surgery for Oropharyngeal Cancer: Long-term Quality of Life and Functional Outcomes.” JAMA Otolaryngology Head Neck Surgery. 2013 Apr 10:1-9. [Epub ahead of print]

129. Dobrosotskaya IY, Bellile E, Spector ME, Kumar B, Feng F, Eisbruch A, Wolf GT, Prince ME, Moyer JS, Teknos T, Chepeha DB, Walline HM, McHugh JB, Cordell KG, Ward PD, Byrd S, Maxwell JH, Urba S, Bradford CR, Carey TE, Worden FP. “Weekly chemotherapy with radiation








CURRICULUM VITAE versus high-dose cisplatin with radiation as organ preservation for patients with HPV positive and HPV negative locally advanced squamous cell carcinoma of the oropharynx (SCCOP). Head & Neck. 2013. [Epub ahead of print]

130. Durmus K, Kakarala K, Old MO, Teknos TN, Ozer E. “Anterolateral Thigh Butterfly Free Flap Reconstruction For Peristomal Recurrence Following Laryngectomy: Our Experience In Six Patients.” Clinical Otolaryngology. 2013 Apr 26. [Epub ahead of print]

131. Tassone P, Old M, Teknos TN, Pan Q. “p53-based therapeutics for head and neck squamous cell carcinoma.” Oral Oncology. 2013 Apr 25. [Epub ahead of print]

132. Islam M, Sharma S, Kumar B, Teknos TN. “Atorvastatin inhibits RhoC function and limits head and neck cancer metastasis.” Oral Oncology. 2013 May 3. [Epub ahead of print]

133. Azeem K, Kumar B, Kumar P, Wakely Jr. P, Kirsch C, Old MO, Agrawal A, Ozer E, Carrau R, Schuller D, Siddiqui F, Teknos TN. “Highly Aggressive HPV-related Oropharyngeal Cancer: Clinical Radiologic, and Pathologic Characteristics.” Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology. [In press]

134. Xie X, Piao L, Cavey GS, Old M, Teknos TN, Mapp AK, Pan Q. “Phosphorylation of Nanog is

essential to regulate Bmi1 and promote tumorigenesis.” Oncogene. 2013 May 27. [Epub ahead of Print]

135. Durmus K, Rangarajan SV, Old MO, Agrawal A, Teknos TN, Ozer E. Transoral robotic approach to carcinoma of unknown primary. Head & Neck. 2013 May 29. [Epub ahead of print].

136. Zhang M, Taylor CE, Piao L, Datta J, Bruno PA, Bhave S, Su T, Lang JC, Xie X, Teknos TN, Mapp AK, and Pan Q. “Genetic and chemical targeting of epithelial-restricted with serine box reduces epidermal growth factor receptor and potentiates the efficacy of afatinib.” Molecular Cancer Therapeutics. 2013 Aug.

137. Marcinow AM, Hall N, Byrum E, Teknos TN, Old MO, Agrawal A. Use of a novel receptor- targeted (CD206) radiotracer, 99mTc-tilmanocept, and SPECT/CT for sentinel lymph node detection in oral cavity squamous cell carcinoma: initial institutional report in an ongoing phase 3 study. JAMA Otolaryngology Head and Neck Surgery. 2013 Sep.

138. Su T, Straight S, Bao L, Xie X, Lehner CL, Cavey GS, Teknos TN, Pan Q. PKC ε Phosphorylates and Mediates the Cell Membrane Localization of RhoA. ISRN Oncology. 2013 Sep 29.

139. Marcinow A, Ozer E, Teknos T, Wei L, Hurtuk A, Old M, Agrawal A, Carrau R, Iwenofu OH. Clinicopathologic predictors of recurrence and overall survival in adenoid cystic carcinoma of the head and neck: A single institutional experience at a tertiary care center. Head & Neck. 2013 Oct 25. [Epub ahead of print].

140. Akagi K, Li J, Broutian TR, Padilla-Nash H, Xiao W, Jiang B, Rocco JW, Teknos TN, Kumar B,


CURRICULUM VITAEWangsa D, He D, Ried T, Symer DE, Gillison ML. Genome-wide analysis of HPV integration in human cancers reveals recurrent, focal genomic instability. Genome Research. 2014 Feb 24. Epub 2013 Nov 7.

141. Santaliz-Ruiz LE, Xie X, Old M, Teknos TN, Pan Q, James AG, Solove RJ. Emerging role of nanog in tumorgenesis and cancer stem cells. International Journal of Cancer. 2013 Dec 21. [Epub ahead of print].

142. Bradford CR, Kumar B, Bellile E, Lee J, Taylor J, D’Silva N, Cordell K, Kleer C, Kupfer R, Kumar P, Urba S, Worden F, Eisbruch A, Wolf GT, Teknos TN, Prince ME, Chepeha DB, Hogikyan ND, Moyer JS, Carey TE. Biomarkers in advanced larynx cancer. The Laryngoscope. 2014 Jan.

143. Chinn SB, Spector ME, Bellile EL, Rozek LS, Lin T, Teknos TN, Prince ME, Bradford CR, Urba SG, Carey TE, Eisbruch A, Wolf GT, Worden FP, Chepeha DB. Efficacy of induction selection

chemotherapy vs primary surgery for patients with advanced oral cavity carcinoma. JAMA Otolaryngol Head and Neck Surgery. 2014 Feb 1. [PubMed - in process]

144. Arshad H, Ozer HG, Teatcher A, Old M, Ozer E, Agrawal A, Jafari H, Birkheimer D, Basinger H, Forrest A, Schuller DE, Teknos TN. "ICU vs. Non-ICU Postoperative Management of Head and Neck Free Flaps: Comparative Effectiveness and Cost Comparisons." Head & Neck. [In press].

145. Kasemsiri, P; Prevedello D; Otto B; Old MO; Ditzel L; Teknos TN; Ozer E; Agrawal A; Kassam A; Carrau R. Surgical Treatment of Nasopharyngeal Malignancies: Role of Endoscopic Endonasal Approaches. Journal of Nasopharyngeal Carcinoma. [Submitted].

146. Teknos TN, Kuppusamy P, Kumar B, Yadav A, Kalman H, Kumar P. A novel curcumin analog (H-4073) enhances the therapeutic efficacy of cisplatin treatment in head and neck cancer. PLoS One. [Accepted].

147. Islam M, Datta J, Lang JC, Teknos TN. Down regulation of RhoC by MicroRNA-138 results in de-activation of FAK, Src and Erk1/2 signaling pathway in head and neck squamous cell carcinoma. Oral Oncology, 2014 [Epub ahead of print].

148. Islam, M, Sharma S, Teknos TN. RhoC Regulates Cancer Stem Cells in Head and Neck

Squamous Cell Carcinoma by Overexpressing IL-6 and Phosphorylation of STAT3. PLoS One 2014. [In press].

149. Zhang M, Kumar B, Piao L, Xie X, Schmitt A, Arradaza N, Cippola M, Old M, Agrawal A, Ozer E, Schuller DE, Teknos TN, Pan Q. Elevated intrinsic cancer stem cell population in human papillomavirus-associated head and neck squamous cell carcinoma. Cancer. 2014 Apr 1. Epub 2013 Dec 30.

150. Durmus K, Patwa HS, Gokozan HN, Kucur C, Teknos TN, Agrawal A, Old MO, Ozer E. Functional and quality-of-life outcomes of transoral robotic surgery for carcinoma of unknown primary. The Laryngoscope. 2014 Apr 5. [Epub ahead of print].


CURRICULUM VITAE151. Calli C, Teknos TN, Agrawal A, Schuller DE, Ozer E, Songu M. Does Body Mass Index Matter

While Selecting the Flap Type for Pharyngeal Reconstructions? Journal of Craniofacial Surgery. 2014 Apr 29. [Epub ahead of print].

Chapters In Books1. Teknos TN, Coniglio JU, Netterville JL. Guidelines to Patient Management. In: Bailey B, ed.

Head and Neck Surgery – Otolaryngology, 2nd Edition, 1998:1369-1376.

2. Teknos TN, Coniglio JU, Netterville JL. Guidelines to Patient Management. In: Bailey B, ed. Head and Neck Surgery – Otolaryngology, 3rd edition, 2001:1181-1186.

3. Chepeha DB, Teknos TN. Microvascular Reconstruction. Bailey B. ed. Otolaryngology Head and Neck Surgery, 3rd edition, 2001:2045-2067.

4. Teknos TN, Chepeha DB, Bradford CR. Jejunal Free Tissue Transfer. In: Burkey, Futran, eds. Head and Neck Reconstruction with Microvascular Application. In press.

5. Teknos TN. Scalp Reconstruction Using Microvascular Free Tissue Techniques. In: Toriumi, ed. Facial Plastic and Reconstructive Surgery. In press.

6. Teknos TN: Head and Neck. In: Greenfield, ed. Surgery: Scientific Principles and Practice, 3rd edition, 2001:645-658.

7. Teknos TN, Chepeha, DB, Wang S. Secondary Oral Cavity Reconstruction. In: Day T, Girod DA, ed. Reconstruction of the Oral Cavity. Taylor and Francis Group Publishing, NY 2006.

8. Moyer JS, Teknos TN. Head and Neck In: Mulholland MW, Lilliemoe KD, Doherty GM, Maier RV, Upchurch GR, ed. Greenfiled’s Surgery Scientific Principles and Practice, 4th Edition. Lippincott Williams and Wilkins Publishing, Philadelphia, PA 2006

9. Moyer JS, Teknos TN. Diagnosis and Management of Head and Neck Endocrine Malignancies, in Singh S and Petruzzelli Practical Head and Neck Oncology. In Press.

10. Wang SJ, Chepeha DB, Teknos TN. Complications of Microvascular Free Flap Surgery, in Dr. Eisele ed. Complications in Head and Neck Surgery. In Press.

11. Emerick KE, Teknos TN. Scapular Free Tissue Transfer, in Bryne P ed. Facial Plastic Surgery. In Press.

12. Moyer, JS, Chepeha DB, Teknos TN. Reconstruction of the Tongue: In 1 st ed. Werning JW. Oral Cancer: Diagnosis, Management, and Rehabilitation. Thieme Medical Publishers, New York, Stuttgart, May 2007.

13. Thieme, “Reconstruction of the Head and Neck” New Volume Series Masters Techniques in Otolaryngology/Head & Neck Surgery, Arsha H, Kakaralla K, Teknos TN, Oropharyngeal and soft palate defects; Parotid defects. In Press 2012.


CURRICULUM VITAE14. Arshad H, Old M, Teknos TN. "Benign Salivary Gland Neoplasms." In Head and Neck Cancer:

Multimodality Management (In submission). (In Press). 100% Authorship.

15. Teknos TN, Genden Eric, “Reconstruction of the palate with a palatal island flap” in Masters in Otolaryngology. 2013.

Published Book Review1. Teknos TN. Review of Berish Strauch, Han-Liang Yu. Atlas of Microvascular Surgery:

Anatomy and Operative Techniques. Second Edition, 2006. Archives of Facial Plastic Surgery, published January 2008.


Date post:	27-Mar-2018
Category:	Documents
Upload:	vucong
View:	213 times
Download:	1 times

Theodoros N - Ohio State University · Web viewColumbus, OH Education and Training LEAN...

Documents